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 Intracellular levels of the RNA-binding protein and pluripotency factor, 
Lin28a, are tightly controlled to govern cellular and organismal growth. Lin28a is 
extensively regulated at the post-transcriptional level, and can undergo mitogen-
activated protein kinase (MAPK)-mediated elevation from low basal levels in 
differentiated cells by phosphorylation-dependent stabilizing interaction with the 
RNA-silencing factor HIV TAR-RNA-binding protein (TRBP). However, molecular 
and spatio-temporal details of this critical control mechanism remained unknown.  
In the second chapter of this work, we dissect the interacting regions of Lin28a 
and TRBP proteins and develop a sensor to visualize this interaction. We identify 
truncated domains of Lin28a and of TRBP that are sufficient to support co-
association and mutual elevation of protein levels, and a requirement for MAPK-
dependent phosphorylation of TRBP at putative ERK-target serine 152 in 
mediating increase of Lin28a protein by TRBP. The phosphorylation-dependent 
association of Lin28a and TRBP truncated constructs is leveraged to develop a 
FRET-based sensor for dynamic monitoring of Lin28a and TRBP interaction. We 
demonstrate response of this FRET sensor to growth factor stimulation in living 
cells, with coimaging of Erk activation to achieve further understanding of the role 
of MAPK signaling in Lin28a regulation.  
 The IB kinase (IKK) is a key mediator of NFB activation, which affects 
inflammatory signaling. In the third chapter of this work, we expand our focus 
from Lin28a to review the process of biosensor development for kinase activity, 
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taking as a case study our efforts to develop a FRET-based biosensor for IKK. 
We successfully identified an IKK substrate peptide that could be inducibly 
phosphorylated, and had some success in visualizing this substrate’s 
phosphorylation. However, further optimization will be required to engineer a 
sensor that reliably diffuses throughout the cell and does not perturb the NFB 
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Introduction to cell signaling 
Cells process external information through signal transduction to evoke 
appropriate responses. Post-translational modifications to proteins, such as 
phosphorylation, glycosylation, and methylation, offer a group of mechanisms for 
rapidly changing the function of proteins and pathways to mediate signal 
transduction. These modifications are generally executed by enzymes, such as 
kinases for phosphorylation and phosphatases for removal of phosphate groups. 
Because of the dynamic and reversible nature of phosphorylation, and its broad 
spectrum of effects on protein function, understanding the activity of such 
enzymes is of great interest. Since their first introduction in the late 1990s, 
genetically encodable FRET sensors for kinase activity and second messengers 
have emerged as powerful tools to probe cellular signaling events (Mehta & 
Zhang, 2011). Chapter 3 of this thesis gives a more in-depth review of the 
development and implementation of FRET biosensors, especially for kinase 
activity, and their utility for understanding localized changes within cells.  
Neurons are highly compartmentalized and specialized signaling cells, 
encoding a high degree of complexity to carry out their function. Differentiated 
neurons have extraordinarily complicated signaling architectures, with many 
levels of compartmentalization, from large divisions such as dendrite/axon/soma, 
to macrocompartments such as dendritic spines, to microcompartments such as 
those found in the neighborhood of receptors at the synapse. Each of these 
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signaling environments maintains a unique identity and contributes to the cell’s 
capacity for input, summation, coincidence detection, and many other 
computations without which cognition would be impossible. Studies using real-
time kinase and second messenger indicators in differentiating neurons have 
furthered our understanding of the specification of these signaling environments 
from undifferentiated neurites (Shelly et al., 2010; Shelly et al., 2011). In mature 
neurons, biosensor probes are useful in understanding how biochemical 
computations occur, which kinases participate in spatially-restricted signaling, 
and what functional sub-compartments are involved in mediating synaptic inputs. 
 
Signaling in synaptic plasticity 
 Hippocampal pyramidal neurons are an excitatory cell type in the 
hippocampus. Their architecture is highly complex, with a tree-like dendritic arbor 
branching out from the soma. Budding from each dendrite are numerous 
dendritic spines, each of which can receive excitatory synaptic inputs from other 
neurons. At synapses, the spine is closely apposed to the axon terminal of 
another neuron. Within the spine, a region called the postsynaptic density is a 
cluster of densely packed neurotransmitter receptors, scaffolding proteins, and 
signal transduction factors. In response to repetitive trains of release of the 
excitatory neurotransmitter glutamate by presynaptic neurons, signaling 
originating from within the PSD transduces to the rest of the neuron, enabling 
synapses to increase in strength, a phenomenon known as long-term 
potentiation (LTP) (reviewed by Kennedy, 2000). 
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LTP occurs in two phases. In the early stage, calcium-dependent 
cytoskeletal changes mediate growth of the spine, and receptor trafficking to the 
postsynaptic membrane mediates an increase in responsiveness to 
neurotransmitter release. Lee and colleagues showed using a FRET-based 
activity probe that the calcium dependent kinase CaMKII is activated only in 
individual stimulated spines, and that kinase activation level is proportional to the 
growth of the spine (Lee et al., 2009). Meanwhile, signaling events induce 
translation both local to and distal from the synapse. If translation is blocked, 
early stage spine growth is transient, and the spine reverts to its baseline size 
within about an hour (Yang et al., 2008). New protein synthesis enables lasting 
changes to the size and strength of synaptic connections. Because stronger 
connections mediate better neuronal communication, long-term potentiation has 
come to be appreciated as a cellular correlate of learning-induced plasticity 
(Kandel, 2001). 
Autocrine BDNF release after glutamate stimulation of a single spine 
indicates a crucial role for brain-derived neurotrophic factor (BDNF) in LTP 
(Harward et al., 2017). When BDNF signaling is blocked, glutamate alone can 
induce transitory spine growth, but is not adequate to induce enduring LTP 
(Montalbano et al., 2013; Tanaka et al., 2008). In vivo, BDNF plays an integral 
role in memory formation, with knockout animals showing defects in long-term 
potentiation (Patterson et al., 1996) and spatial learning (Linnarsson et al., 1997). 
In dissociated hippocampal neuron culture, BDNF treatment results in increased 
dendritic arborization (Cohen-Cory et al., 1999) and greater abundance and size 
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of dendritic spines (Alonso et al., 2004). Importantly, there is evidence that 
spatial restriction of BDNF availability within a neuron limits these changes to the 
areas exposed to BDNF (Horch & Katz, 2002; Tanaka et al., 2008; Aakalu et al., 
2001). 
 
Excitatory signaling through BDNF  
After binding of glutamate to postsynaptic NMDA receptors, the 
calmodulin dependent kinase CamKII is activated, triggering autocrine release of 
BDNF (Harward et al., 2017). BDNF is recognized by the receptor tyrosine 
kinase TrkB, whose homodimerization and autophosphorylation activate 
numerous signaling pathways, including MAPK/Erk, PI3K/Akt/mTor and 
phospholipase C (see figure 1.1) (reviewed by Chao, 2003). These pathways 
affect both translation-independent and translation-dependent mediators of LTP.  
BDNF induces translation-independent short-term strengthening of 
synaptic connections through protein trafficking and modulation of cytoskeletal 
dynamics. TrkB activation causes NMDA receptor insertion into the postsynaptic 
membrane (Caldeira et al., Mol Cell Neurosci 2007), and scaffolding protein 
PSD95 localization to the postsynaptic density (Yoshii and Constantine-Paton, 
2010). BDNF also promotes changes in actin dynamics through GTPase activity. 
RhoA-induced activation of Lim kinase 1 inhibits the actin protease cofilin in 
dendritic spines, allowing for actin polymerization, while Rac stimulates the 
kinase PAK, regulating actin branching (Rex et al., 2007). Together, these 
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translation-independent changes strengthen the synaptic response to each 
neurotransmitter release and increase the size of the spine. 
Translation-independent changes to cytoskeletal dynamics and receptor 
localization are reinforced by changes in local protein synthesis, which are 
required for enduring synaptic plasticity. Dendrites have been known for some 
time to be competent to translate new proteins in response to BDNF, even if 
separated from the cell body (Bradshaw et al., 2003; Huang & Kandel, 2005; 
Kang & Schuman, 1996). BDNF induces an increase in synaptic protein 
translation through Erk-dependent pathways, which are discussed in the next 
section. Local translation adds to the available pool of receptors and signaling 
proteins (Schratt et al., 2004). BDNF also mediates local synthesis of the 
GTPase RhoA (Briz et al., 2015), the cytoskeleton-associated scaffolding protein 
Arc (Messaoudi et al., 2007; Bramham et al., 2010), and many components of 
the translation machinery including translation factors and ribosomal proteins 
(Caravalho et al., 2008; Aakalu et al., 2001; Liao et al., 2007).  
Other effects of BDNF on gene expression depend on long-range 
signaling to the nucleus to activate transcription of target genes. A number of 
transcription factors, including NFκB, CREB and NFAT, can be activated by 
BDNF and translocate from the dendrite or synaptic spine to the nucleus (Meffert 
et al., 2006; Pizzorusso et al., 2000; Groth & Mermelstein, 2003). Similarly, some 
enzymes, including the MAP kinase Erk (Patterson et al., 2001) can be 




Erk signaling in synaptic plasticity 
The MEK/Erk pathway is a well-known intermediate in the response to 
BDNF, activated by TrkB within minutes after BDNF treatment (Ying et al., 2002). 
Erk activity is absolutely required for long-term potentiation (LTP) (English et al., 
1996; Davis et al., 2000) and for lasting BDNF-induced increases in spine size 
and density (Alonso et al., 2004; Huang et al., 2012). While some Erk pathway 
targets function at the synapse to reinforce LTP, this kinase also induces 
signaling to and itself translocates to the nucleus, where it induces further 
changes in mRNA expression (Cohen et al, 2011; Wiegert et al., 2007).  
 Like all kinases in the MAPK family, Erk1/2 is activated by a highly specific 
response pathway. Downstream of receptor tyrosine kinases such as TrkB, 
GTPases, such as Ras, activate serine/threonine MAP3Ks, such as Raf. Active 
MAP3K phosphorylates a dual-specificity MAP2K, such as MEK, which 
phosphorylates the activation loop of Erk1/2 at threonine 183 and tyrosine 185 
(Canagarajah et al., 1997). This pathway can also be activated Rtk-
independently through crosstalk with other signaling pathways. For example, Ras 
GTPase can be activated by PKC, e.g. by the direct PKC activator PMA 
(Mendoza et al., 2011).  
Once activated, MAPKs can phosphorylate serine or threonine residues, 
dependent on presence of a proline in the next residue. Studies of 
phosphorylation on purified peptides indicate that PX[S/T]P is a strong substrate 
for ERK1/2 (Gonzalez et al., 1991). Substrate specificity is also conferred by 
docking motifs within the MAPK substrate, near but not within the substrate site. 
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Some important docking motifs include the D box, a lysine/arginine-rich docking 
motif, and the amino acid sequence DEJL, which are recognized both by Erk and 
by its fellow MAP kinase JNK; and an FXFP motif, which mediates only Erk 
docking, and dramatically enhances the rate of phosphorylation (Jacobs et al., 
1999). 
 
Erk diffusibility- mechanisms and means of study 
MAPK signaling can be spatially controlled by molecular scaffolding, which 
can mediate activation of a kinase, directly control its localization, or drive 
selection of substrates by enhancing kinase/substrate proximity (Dhanasekaran 
et al., Oncogene 2007). At the synapse, a scaffolding protein, Homer, can 
directly bridge metabotropic glutamate receptor 5 (mGluR5) to Erk to mediate 
kinase activation after stimulation of the receptor (Mao et al J Neursoci 2005). 
The scaffolding protein kinase suppressor of Ras 1 (KSR1), controls 
compartmentalization of MEK and Erk to the dendritic spine or shaft in a 
homeostatic fashion, such that Erk-induced phosphorylation of KSR1 drives 
exclusion of KSR1 and Erk from the spine (Canal et al., 2011). Moreover, active 
Erk binds to importins and translocates to the nucleus, where it is released to 
phosphorylate nuclear substrates including a variety of transcription factors and 
repressors and chromatin remodeling factors(Li et al., 2016; Wainstein et al., 
2016; Plotnikov et al., 2011). 
FRET imaging using biosensors for kinase or other enzymatic activity has 
been an extremely beneficial tool to observe spatial control of signaling activity in 
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neurons. Certain enzymes such as CaMKII and Cdc42 are activated strictly in 
synaptic spines exposed to glutamate uncaging, giving a long-lasting mechanism 
for spine differentiation from inactive synapses (i.e., synaptic tagging) (Lee et al., 
2009; Hedrick et al Nature 2016). In contrast, other GTPases, including Ras, 
Rac1 and RhoA, can diffuse out of the activated spine, priming nearby spines for 
stronger response to sub-threshold stimuli (Hedrick et al., 2016; Yasuda & 
Murakoshi, 2011; Harvey et al., 2008). In the case of Erk1/2, recent work shows 
that its activity is highly diffusible between a single activated dendritic spine and 
both the associated dendrite and neighboring spines (Tang and Yasuda, 2017).  
 
Downstream targets of Erk in synaptic plasticity 
 Erk supports rapid changes to synaptic transmission through 
phosphorylation of glutamate receptors mGluR1 and 5; the voltage-gated 
potassium channel Kv4.2; and scaffolding proteins of the post-synaptic density 
(reviewed by Thomas & Huganir, 2004).  
Among Erk’s other substrates in the spine are fellow kinases such as 
MSK1 (Correa et al., 2012) and MNK1. Activated MNK1 phosphorylates 
translation initiation factor eIF4E, increasing association between the initiation 
factor and mRNA granules, and promoting its translocation to the spine, thereby 
upregulating synaptic translation (Panja et al., 2014; Takei et al., 2001; Smart et 
al., 2003). MNK may also relieve individual transcripts from binding by the 




Erk activity also supports signaling to the nucleus through its own 
translocation and through activation of transcription factors including NFkB, Elk1 
and CREB (reviewed by Thomas & Huganir, 2004).  Erk-dependent BDNF target 
genes include both synaptic gene products such as Homer and Arc, and other 
genes such as long noncoding RNAs and primary microRNA transcripts 
(Messaoudi et al., 2007; Bluthgen et al., 2017; Jaitner et al., 2016). 
 
Canonical miRNA biogenesis 
Changes to cellular protein concentration can be achieved efficiently, and 
without requiring de novo transcription, by modulations to microRNA levels (Baek 
et al., 2008; Selbach et al., 2008). MicroRNAs are transcribed in the nucleus as 
pri-miRNAs, which are processed by Drosha and its cofactor DGCR8, a complex 
known as the microprocessor, before export into the cytoplasm in stem-and-loop 
pre-miRNA form. The nuclease enzyme Dicer, in complex with its cofactor TRBP, 
the Tar RNA binding protein, cleaves pre-miRNA into mature microRNAs in the 
cytoplasm. Mature miRNAs assemble into an Ago2-containing complex known as 
RNA induced silencing complex (RISC), which modulates translation of target 
mRNAs (See figure 1.2A). 
 
Signal-responsive changes to miRNA biogenesis 
To control mature miRNA level and repressive activity, Microprocessor 
and Dicer activity are required. Post-translational regulation of microRNA 
biogenesis factors is increasingly appreciated as a mechanism for tuning miRNA 
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biogenesis (Ha & Kim, 2014). For example, DGCR8 phosphorylation by MAPK 
signaling can alter miRNA output (Herbert et al., 2013). Moreover, post-
translational modification of RISC components can occur at the synapse; such 
modifications can provide a link between signaling and the rapid proteome 
changes observed at the synapse (Sambandan et al., 2017).  
 
miRNA changes in synaptic plasticity 
 Given the importance of local translation within the dendrite to LTP 
described above, it is increasingly appreciated that microRNA biogenesis in the 
dendrite can exert control of the genes translated there. Inducible deletion of 
Dicer in the forebrain of adult mice leads to significant upregulation of BDNF, 
PSD95 and GluA1, indicating that microRNAs play a significant role in 
modulating protein expression and synaptic responses (Konopka et al., 2010). 
 There is considerable evidence for changes to specific microRNAs 
resulting from coordinated changes to transcription and RISC activity. Activity-
induced transcription is a key contributor to synaptic pre-miRNA availability. 
BDNF activates Satb2, a forebrain specific chromatin remodeling protein, to 
upregulate transcription of both protein-coding and miRNA-encoding genes 
(Jaitner et al., 2016).  BDNF induces Erk- and CREB-dependent upregulation of 
miR-132, which represses a GTPase activating protein, prolonging Rac1 
activation (Vo et al., 2010; Kawashima et al., 2010; Huang et al., 2012). In 
addition to inducing repression of specific protein targets, BDNF-induced miRNA 
modulation can also relieve repression of protein translation. For example, miR-
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134 acts post-transcriptionally on plasticity associated enzymes including actin 
polymerizing lim kinase 1 (Schratt et al., 2006). At baseline, miR-134 represses 
LIMK1; treatment with BDNF allows LIMK1 to be translated. Similarly, miR-134 
represses Ras palmitoylating enzyme DHHC9 in neurons (Chai et al., 2013). The 
net effect of miR-134 is to suppress dendritic spine size and synaptic plasticity 
factors (Gao et al., 2010), and it may be upregulated after synaptic activity, 
perhaps supporting a homeostatic function (Bicker et al.,  2014).  
Another example of relief of repression downstream of BDNF involves the 
Let-7 family. This group of 13 coordinately regulated microRNAs is highly 
abundant in the brain (Roush & Slack, 2008). Deep sequencing indicates that 
almost half of small RNAs expressed in rat hippocampus belong to the let-7 
family (Shinohara et al., 2011; Juhila et al., 2011). Laser-capture dissection 
experiments indicate that several let-7s may be differentially regulated in the 
neurite and soma (Kye et al., 2007). Let-7 miRNA levels are rapidly reduced in 
response to BDNF activity, enabling rapid up-regulation of translation from target 
mRNAs such as CamKII alpha and Arc (Huang & Ruiz et al., 2012). More 
comprehensive reviews of miRNA function in synaptic plasticity have been 
written by Aksoy-Aksel et al. (2014) and McNeill and Van Vactor (2012).  
 
TRBP: a microRNA biogenesis cofactor 
TRBP, the Tar RNA binding protein, is a cytoplasmic cofactor to Dicer and 
aids in processing of pre-miRNAs to mature microRNAs. As its name suggests, 
this protein was discovered in connection with the HIV genome component Tar 
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RNA; TRBP overexpression potentiates HIV replication, because TRBP 
represses the interferon inducing, dsRNA-stimulated protein kinase R (PKR) 
(reviewed by Daniels and Gatignol, 2012). TRBP can also bind to and inhibit a 
fellow dsRNA binding protein, the protein activator of PKR (PACT) (Daher et 
al.,2009). TRBP exerts PKR-independent cellular effects in complex with Dicer, 
where TRBP is believed to feed pre-miRNAs into the Dicer active site and 
facilitate RISC loading (Wilson et al., 2015).  
 
Post-translational modifications to TRBP 
TRBP is highly regulated in response to signaling, with studies identifying 
up to ten phosphorylated residues (Kim et al., 2014). Posttranslational 
modifications govern the protein’s stability and affinity for various binding 
partners; some of these modifications have been shown to mediate changes in 
miRNA processing.  
Phosphorylated TRBP is present in the RISC, and Erk overexpression 
enhances, while inhibition diminishes, its abundance in this complex (Paroo et 
al., 2009). A phosphomimic construct, mutated at four serines identified by mass 
spectrometry, enhances Dicer binding and miRNA maturation (Paroo et al., 
2009). Of those four residues (serines 142,152, 283, and 286), two in the C 
terminus of the protein have subsequently been shown to be substrates of S6 
kinase 2, a protein kinase generally activated downstream of mTor. (Warner et 
al., 2016). The authors of the latter study postulated that concurrent 
phosphorylation of TRBP by Erk, presumably in the linker region between 
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double-stranded RNA binding motifs (dsRBMs) 1 and 2, and S6K2 in the C-
terminal domain may collaborate to increase TRBP/Dicer binding and miR 
maturation downstream of the receptor tyrosine kinase for angiopoietin (Warner 
et al., 2016). Erk phosphorylation also enhances SUMOylation of TRBP, which 
may contribute to improved RISC formation, and which reduces TRBP 
ubiquitination and degradation (Chen et al., 2015). 
In contrast, TRBP is hyperphosphorylated by JNK during mitosis, a 
modification independent of Erk activity that does not affect Dicer binding but 
does enhance binding to, and inhibition of, protein kinase R (Kim et al., 2014). 
This phosphorylation, independently confirmed in a constitutively active JNK1 
setting, can be reduced by S-to-A mutation at serine 142 and abolished by 
combining S142A and S152A mutations (Nakamura et al., 2015).  
The residues in TRBP that are MAPK substrates are incompletely 
elucidated but, taken together, the data (Paroo et al; Kim et al; Nakamura et al) 
suggest that serines 142 and 152, located in the linker region between TRBP 
dsRBM1 and dsRBM2, may be regulated by both JNK and Erk. These kinases 
are known to share overlapping substrate motifs in other proteins; for example, 
specific serines in the transcription factors Elk1 and JunD have been observed to 
be phosphorylated by both JNK and Erk (reviewed by Bogoyevitch and Kobe, 
2006). 
TRBP phosphorylation regulates its stability and binding partner selection, 
mediating signaling in various physiological and disease contexts: it promotes 
HIV infection of T cells (Sanghvi et al., 2011), stress-response signaling (Daniels 
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& Gatignol, 2012) and obesity (Nakamura et al., 2015), and as has been recently 
shown, can control microRNA regulation through simultaneous binding to Dicer 
and lin28a in hippocampal synaptic plasticity (Amen et al., 2017).  
 
Lin28a- a pluripotency-mediating protein 
Lin28a is a pluripotency factor critical for numerous developmental and 
cellular signaling pathways (Jiang & Baltimore, 2016). It represses Dicer 
processing of the let-7 family of microRNAs (miRNAs) and several related 
miRNAs by binding to the stem-loop structure of pre-miRNAs. After binding, 
Lin28a recruits one of two terminal uridyltransferases (TUT4 or TUT7) to pre-let7 
miRNAs to reduce availability for Dicer processing (Hagan et al., 2009, Heo et 
al., 2012, Thornton et al., 2012). Although monouridylation potentiates microRNA 
biogenesis, polyuridylated miRNAs cannot be processed by Dicer into mature 
form (Heo et al., 2008). Moreover, the 3’-5’ exonuclease DisL32 degrades 
polyuridylated RNAs preferentially (Chang et al., 2013, Viegas et al., 2015). 
Lin28a has been reported to localize in ribonucleoprotein complexes in the 
cytoplasm including in RNA-processing bodies (P bodies), where it colocalizes 
with translation-associated proteins such as elongation factors eIF3B and eIF4E 
and RNA helicase A (Balzer and Moss, 2007; Jin et al., 2011).  
While it inhibits let-7 miRNA processing, Lin28a is itself translationally 
repressed by mature let-7 miRNAs (Rybak et al., 2008). Therefore, Lin28a and 
let-7 microRNAs form a bistable switch; upregulation of either reduces levels of 
the other (Viswanathan et al., 2008; Heo et al., 2008; Newman et al., 2008). A 
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change in switch state from high Lin28a protein level to high mature let-7 
microRNA level is associated with the transition from stem or progenitor cell to 
adult tissue, and generally occurs at the late embryonic stage (Thomson et al., 
2004; Wulczyn et al., 2007; Sempere et al., 2004). 
Numerous biochemical studies have investigated the functional domains 
of Lin28a and the precise mechanism by which they recognize and inhibit 
processing of the protein’s miRNA precursor targets. The protein has two 
conserved dsRNA binding domains: a cold-shock domain (CSD), from aa 39-
112; and an RNA-binding CCHC zinc knuckle domain (ZKD), from aa 136-176 
(figure 1.2b). A crystal structure of truncated Lin28a in complex with a pri-let-7 
shows interfaces at the terminal loop of the microRNA, with the Lin28a CSD 
inserted into the precursor loop and the ZKD binding double-stranded sequence 
ancillary to the terminal loop (Nam et al., 2008). Subsequent work demonstrated 
that lin28a binding specificity is driven by a GGAG motif in the terminal loop of 
pre-miRNAs in the let-7 family, and also substrates such as miR-143 and miR-
107 (Heo et al., 2009). Both Lin28 proteins contain a cold-shock domain (CSD) 
and two CCHC-type zinc-finger domains that bind respectively to the GNGAY 
consensus sequence (Y, pyrimidine; N, any base) in the let-7 preE loop and a 
conserved GGAG motif near the 3’ end of the let-7 preE bulge (Ali et al., 2012; 
Heo et al., 2009; Loughlin et al., 2012; Mayr et al., 2012; Nam et al., 2011; 
Piskounova et al., 2008; Wang et al., 2017). Truncation experiments indicate that 
either the cold shock domain, or the zinc knuckles in isolation, may suffice to bind 
to miRNA precursors. Remodeling of the pre-miRNA terminal loop to occlude 
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Dicer cleaving site is mediated by the lin28 CSD, which may also drive 
multimerization of lin28 on pre-let-7s (Mayr et al., 2012; Desjardins et al., 2014). 
On the other hand the ZKD can also bind pre-miRNAs, with affinity partly driven 
by miRNA identity (Nowak et al., 2017). Expressed in isolation, the zinc knuckles 
are adequate to bind a microRNA stem-loop, recruit TUT4, and mediate 
oligouridylation (Wang et al., 2017) 
 Lin28a can bind to mRNA as well as microRNA, targeting a GGAGA motif 
in mRNAs; Lin28a binding is believed to mediate mRNA splicing and translation 
(Wilbert et al., 2012; Lei et al., 2012). Lin28 binding has been reported to directly 
enhance translation of target genes by driving their inclusion in polysomes (Jin et 
al., 2011; Peng et al., 2011; Polesskaya et al., 2008), as well as to suppress 
translation by an unknown mechanism (Cho et al. 2012). Its reported mRNA 
targets include its own mRNA and numerous fellow RNA binding proteins, 
signaling proteins, and cyclins in progenitor cells of various tissues (Hafner et al., 
2013; Polesskaya et al., 2008; Xu et al., 2009).  Relative contributions of lin28a 
mRNA binding and pre-miRNA binding to the total physiological effect of lin28a 
are debated. 
 Moreover, a recent publication adds a layer of complexity by 
demonstrating that Lin28a has the capability to bind dsDNA, and might bind to 
single-stranded promoters with a purine-rich motif, distinct from but similar to its 
GA-rich RNA targets, to regulate gene expression (Zeng et al., 2016)  
 
Lin28B: a lin28a paralog with subtly distinct function 
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 Mammalian Lin28a has a homolog, Lin28B. The two proteins share high 
sequence similarity especially from the start of the CSD to the ZKD terminus, 
with nonhomologous sequence concentrated at the N and C termini. The proteins 
differ in primary function: Lin28B tends to act in the nucleus, by sequestering pri-
let-7 miRNAs far from the microprocessor complex, within the nucleolus 
(Piskounova et al., 2011). However, describing lin28a as cytoplasmic and B as 
nuclear would be an oversimplification. Both proteins can be found in both 
compartments, and each binds, albeit with varying affinity, to both pri-let-7s and 
pre-let-7s (Shyh-Chang & Daley, 2013). 
 
Post-translational modifications to lin28a 
 Lin28a methylation, phosphorylation and N-acetylation have been 
reported (Bienvenut et al., 2012; Rigbolt et al., 2011; Van Hoof et al., 2009; Kim 
et al., 2009). Of these modifications, methylation and phosphorylation have 
documented effects on protein function. 
 Lin28a methylation at lysine 135 drives lengthened protein half-life, 
nucleolar localization, multimerization and a preference for binding pri-let-7s over 
pre-let-7s (Kim et al., 2014). This modification drives a striking degree of 
functional overlap between Lin28a and Lin28B. Methylation may extend stem cell 
pluripotency by tightly controlling let7 generation at the primary miRNA stage. 
(Kim et al., 2014).  
 Recent studies have shown that Lin28a can be phosphorylated by Erk 
kinase at a serine residue in the C terminal unstructured region, a modification 
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which increases the stability of the protein, whereas a corresponding 
phosphodeficient mutant is less stable (Tsanov et al., 2017; Liu et al., 2017). 
While the effects of this phosphorylation event on miRNA and mRNA targets of 
lin28a remain in dispute, both groups agree that Lin28a phosphorylation is 
associated with maintenance of pluripotency (Tsanov et al, 2017; Liu et al., 
2017).  
 
Lin28a in endogenous and induced pluripotency 
 Overexpression of Lin28a, with several other pluripotency factors, can 
drive reprogramming and de-differentiation of adult cells into induced pluripotent 
stem cells (Yu et al., 2007; Hanna et al., 2009). As a driver of pluripotency, lin28 
is also a potent oncogene; aberrant expression of the protein is associated with 
numerous human malignancies, reviewed by Jiang & Baltimore (2016). 
 In normally developing mammalian embryos, Lin28a expression is high at 
very early developmental stages. As noted above, over the course of 
development, Lin28a protein is reduced to undetectable levels in most adult 
tissues.  Deletion of Lin28a does not abrogate pluripotency, as Lin28a knockout 
mice can develop past the pluripotent blastocyst stage (Zhu et al., 2010). 
However, data suggest that the protein may be required for self-renewal of 
pluripotent cells (Tanabe et al., 2013; Shyh-Chang & Daley, 2013). Forced 
overexpression of Lin28a delays puberty and drives overgrowth in mice (Zhu et 
al., 2010).  
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Lin28a expression remains detectable in the neural tube and neural crest 
after its expression declines in other cell types (Balzer et al., 2010). Much as 
described on an organismal level, neural-specific reduction of lin28a yields a 
smaller brain, while overexpression drives overgrowth (Yang et al., 2015). The 
protein is required for proliferation of neural progenitor cells (NPCs), and its 
deletion drives cell cycle exit through target mRNAs (Cimadamore et al., 2013, 
Yang et al., 2015). Conversely, injury to the mammalian retina promotes 
transcriptional activation of lin28a, which drives glial proliferation and 
neurogenesis to promote tissue regeneration (Yao et al., 2016). A few recent 
publications have demonstrated other roles for lin28a in adult brain tissue. 
 
Lin28a in differentiated tissues: regulation of metabolism  
 The lin28a/let-7 axis is increasingly recognized as a regulator of growth 
and metabolism. In general, higher levels of lin28a improve glucose tolerance 
and insulin signaling, and vice versa. Inducible overexpression of lin28a in the 
skeletal muscle of transgenic mice improves glucose tolerance and lean body 
mass through derepression of various genes in the PI3K/mTor signaling pathway 
(Zhu et al., 2011). Meanwhile, mice overexpressing let-7 exhibit diminished 
glucose-induced pancreatic insulin secretion driven by numerous let-7 target 
genes in the insulin response signaling pathway (Frost et al., 2011, Shinoda et 
al., 2013). Lin28a protein level is significantly depressed in induced stem cells 
derived from obese adipocyte tissues compared to healthy controls; 
overexpressing lin28a can rescue glucose tolerance, reducing let-7 levels and 
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inflammatory signaling in these stem cells (Perez et al., 2013). In brain tissue, 
hypothalamic Lin28a regulates metabolism (Kim et al., 2017). Overall, there are a 
number of interesting hints that the receptor tyrosine kinase (Rtk) that recognizes 
insulin may upregulate lin28a through the same paths as the Rtk recognizing 
BDNF. 
 
TRBP/lin28a binding- a case of signal responsive miRNA changes 
 Recently, it was demonstrated that TRBP binds to and stabilizes lin28a 
and Dicer concurrently in a manner enhanced by Erk activity and TRBP 
phosphorylation (Amen et al., 2017). This interaction acts as a selective force in 
signal-responsive miRNA biogenesis, whereby stabilized lin28a reduces the level 
of let-7 miRNAs while phospho-TRBP, in complex with Dicer, enhances 
maturation of a majority of miRNAs. (Amen et al., 2017). Circumstantial evidence 
suggests that this interaction may occur in neurons, and that downregulation of 
let-7 microRNAs may provide a mechanism for local translation changes 
downstream of BDNF (Daniel Pham, unpublished). Moreover, a species believed 
to represent lin28a increases by Western blot in response to receptor tyrosine 
kinase-mediated growth factors in various cell lines and tissue types, hinting at a 
widespread role for this protein/protein interaction in growth regulation in various 
contexts (Amen et al., 2017). The recent demonstration of Lin28a 
phosphorylation by Erk opens the possibility that signaling downstream of growth 








Figures and legends. 
 
Figure 1.1 Signaling through BDNF. Reproduced by permission from Duman and 
Valeti, Trends in Neurosciences 35(1), 2012 (doi: 10.1016/j.tins.2011.11.004). 




Figure 1.2. MicroRNA biogenesis factors. (A) MicroRNA biogenesis schematic. 
Reprinted under a Creative Commons license from Barca-Mayo and Lu (2012) 
Fine-tuning oligodendrocyte development by microRNAs. Front. Neurosci 6:13. 
Doi: 10.3389/fnins.2012.00013. (B) Linear schematic of Lin28a protein, with 
crystal structure showing cold shock domain (orange) and zinc knuckles (violet) 
binding to two separate dsRNA structures (gray). (Adapted from PDB 5UDZ 
(Wang et al. Cell Reports 18 2664-2675 (2017)) (C) Alignment of Lin28a (top) 
with Lin28B (bottom), showing high sequence identity within structured domains 
and minimal alignment at N and C termini. 
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Chapter 2. Characterization and dynamic visualization of Lin28a interaction 
with TRBP 
Abstract:  
Intracellular levels of the RNA-binding protein and pluripotency factor, Lin28a, 
are tightly controlled to govern cellular and organismal growth. Lin28a is 
extensively regulated at the post-transcriptional level, and can undergo mitogen-
activated protein kinase (MAPK)-mediated elevation from low basal levels in 
differentiated cells by phosphorylation-dependent stabilizing interaction with the 
RNA-silencing factor HIV TAR-RNA-binding protein (TRBP). However, molecular 
and spatio-temporal details of this critical control mechanism remained unknown.  
In this work, we dissect the interacting regions of Lin28a and TRBP proteins and 
develop a sensor to visualize this interaction. We identify truncated domains of 
Lin28a and of TRBP that are sufficient to support co-association and mutual 
elevation of protein levels, and a requirement for MAPK-dependent 
phosphorylation of TRBP at putative ERK-target serine 152 in mediating increase 
of Lin28a protein by TRBP. The phosphorylation-dependent association of 
Lin28a and TRBP truncated constructs is leveraged to develop a FRET-based 
sensor for dynamic monitoring of Lin28a and TRBP interaction. We demonstrate 
response of this FRET sensor to growth factor stimulation in living cells, with 
coimaging of Erk activation to achieve further understanding of the role of MAPK 







 Lin28a is a pluripotency-associated RNA-binding protein that exerts post-
transcriptional effects to govern many developmental and cellular signaling 
pathways (Jiang et al., 2016). Lin28a promotes pro-growth gene expression in 
part by repressing maturation of the Let-7 family of microRNAs (miRNAs), and 
undergoes reciprocal translational repression by Let-7 miRNAs (Rybak et al., 
2008). Lin28a also controls gene expression through regulation of mRNA 
translation (Cho et al., 2012).  Appropriate control of Lin28a protein levels is 
necessary for correct organismal development. Mice deficient in Lin28a suffer 
perinatal lethality (Shinoda et al., 2013).  Conversely, Lin28a overexpression can 
lead to abnormal growth and metabolic phenotypes (Zhu et al., 2011, Shyh-
Chang et al., 2011), and Lin28a is upregulated in numerous human cancers 
(Viswanathan et al., 2009, Shyh-Chang & Daley, 2013).  Despite a growing 
appreciation for the necessity of tight control of Lin28a in producing appropriate 
gene expression programs, the signaling that regulates dynamic changes in 
Lin28a protein levels remains incompletely understood.  
Recently, we reported rapid signal-dependent induction of Lin28a through 
post-translational regulation of Lin28a protein stability. MAPK pathway activation 
was shown to enhance phosphorylation and binding of the Dicer cofactor, TRBP, 
as well as Dicer itself to Lin28a in a stabilizing interaction (Amen et al., 2017). 
This complex exerts selectivity in miRNA biogenesis, allowing Lin28a to reduce 
the level of Let-7 miRNAs while Dicer enhances maturation of many miRNAs not 
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targeted by Lin28 (Huang & Ruiz et al., 2012).  A Lin28a/TRBP/Dicer protein 
complex was described initially in cultured neurons, but MAPK-dependent TRBP 
phosphorylation and Lin28a elevation were also observed downstream of trophic 
factors in other primary cell types, indicating a widespread role for this interaction 
in regulating growth responses (Amen et al., 2017).  However, molecular details 
of the Lin28a/TRBP interaction, including its timescale and spatial distribution in 
cells, were relatively unexplored. In this work we characterize the biology of 
Lin28a and TRBP interacting domains. We identify a TRBP phosphorylation site 
crucial for signal responsive interaction with Lin28a and leverage this 
characterization to develop a genetically-encoded optical sensor for 
Lin28a/TRBP binding, allowing quantification and spatiotemporal visualization of 
Lin28a/TRBP binding in living cells.  
 
Results: 
A TRBP truncation sufficient to interact with full-length Lin28a.  
 To investigate TRBP-induced elevation of Lin28a protein levels, we first 
identified the region of TRBP required for this response. Truncation mutants of 
TRBP, TRBP A (1 – 105), TRBP B (98 – 234), TRBP AB (1 – 234) and TRBP C 
(228 – 366) (Figure 1A), developed by the Gatignol lab (Daher et al., 2009), were 
tagged with the myc epitope. When co-expressed in HEK 293T cells with flag-
tagged lin28a (FL-Lin28a), TRBP-A and TRBP-B both elevated FL-Lin28a, while 
TRBP-C had no effect. (Figure 1B-C). Expression of TRBP-C was low, even with 
high DNA transfections (Figure S1A).  Dose titration showed that elevation of FL-
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Lin28a protein by TRBP-A and TRBP-B was most readily detected at low FL-
Lin28a expression levels (Figure S1B-C).  Expressed TRBP-A and TRBP-B 
could also elevate levels of endogenous TRBP protein (Figure 1D), in line with a 
previous demonstration that dsRNA binding motifs (dsRBMs) in these two 
truncations mediate TRBP dimerization (Kok et al., 2007). To distinguish effects 
on Lin28a elevation due to the TRBP truncation alone from effects that might 
result from heterodimerization of a TRBP truncation with endogenous TRBP, we 
next carried out experiments in TRBP knockout cells. 
 Coexpression of TRBP-A and TRBP-B with FL-Lin28a in mouse tail 
epithelial fibroblast cells (TEFs) lacking endogenous murine TRBP (Tarbp2 KO) 
(Daher et al., 2009) revealed that TRBP-B, but not TRBP-A, could elevate FL-
Lin28a levels; TRBP-B increased FL-Lin28a comparably to full length TRBP 
expression (Figure 1E-G). Across a range of expression levels in TRBP KO 
TEFs, full length TRBP and the TRBP-B truncation construct produced 
approximately linear FL-Lin28a protein elevations, while no increase in FL-Lin28a 
was observed with TRBP-A (Figure 1G). These results strongly suggested that 
TRBP-B retained the capacity to interact with Lin28a, while effects of TRBP-A 
were absent when endogenous full-length TRBP could not be recruited.  
In previous work, we demonstrated that TRBP can directly bind Lin28a in 
a stabilizing complex (Amen et al., 2017).  Thus, we next compared the 
association of truncations TRBP-A, TRBP-B, and TRBP-AB with FL-lin28a. 
Immunoprecipitation of FL-lin28a from 293T cells showed that TRBP-AB 
coimmunoprecipitated with FL-Lin28a, as did TRBP-B (albeit more weakly), while 
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TRBP-A did not coimmunoprecipitate with FL-Lin28a (Figure 1H).  Collectively, 
these results are consistent with binding and increase of Lin28a by the TRBP-B 
segment of TRBP, but not by the N-terminal or C-terminal segments TRBP-A and 
C. 
 
TRBP phosphorylation at S152 potentiates lin28a elevation  
 TRBP phosphorylation has been shown to increase its stability (Chen et 
al., 2015) and enhance binding to Dicer and other binding partners (Paroo et al., 
2009, Kim et al., 2015).  In addition, we previously showed that a phosphomimic 
TRBP mutant, with four serines mutated to aspartates, exhibited enhanced 
binding to Lin28a in purified protein interactions (Amen et al., 2017). These 
findings implicated MAPK pathway-mediated phosphorylation of TRBP in Lin28a 
binding, without indicating which of the four serine residues was involved.  We 
identified an ‘FXF’ putative Erk docking motif (Gonzalez et al., 1991) within 
TRBP-B, beginning at aa 112.  Two of the serines mutated in the full-length 
phosphomimic construct, S142 and S152, are present in TRBP-B; both serines 
are candidates for proline-directed kinase phosphorylation, but S152 is a closer 
match to an Erk phosphorylation consensus sequence (Figure 2a, PXSP) 
(Jacobs et al., 1999). 
 Immunoblot of lysates from 293T cells expressing myc-TRBP-B revealed 
a multi-banding pattern between 20 and 25 kDa when probed with an antibody 
raised and purified against phospho-S152 TRBP (Figure S2A). Consistently, 
exposure of myc-TRBP-B lysates to lambda phosphatase treatment collapsed 
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the myc-reactive bands to a singlet at the expected molecular weight of TRBP-B 
(Figure 2B). Phorbol 12-myristate 13-acetate (PMA) increases TRBP 
phosphorylation through the MAPK signaling cascade (Paroo et al., 2009). 
Treating 293T cells expressing myc-TRBP-B with PMA led to an increase in 
phospho-S152 TRBP immunoreactivity, which was reduced in lysates from cells 
treated with MAPK/Erk kinase (MEK) inhibitor U0126 (Figure 2C).  We conclude 
that TRBP-B can be phosphorylated within living cells in a MEK dependent 
manner.  To evaluate the role of this TRBP phosphorylation site in producing 
Lin28a elevation, we immunoblotted lysates from 293T cells which were co-
expressing FL-Lin28a and myc-TRBP-B, and treated with either vehicle control, 
PMA, or PMA plus U0126.  Immunoblot showed that FL-Lin28a protein levels 
were increased by myc-TRBP-B expression, and that PMA treatment further 
enhanced Lin28a elevation in a manner blocked by U0126 (Figure 2C-D).  
We next conducted experiments in TRBP KO TEFs to evaluate the role of 
the putative ERK phosphorylation site TRBP S152 in conferring stimulus-
mediated Lin28a elevation by TRBP-B.  A phosphomutant myc-TRBP-B with 
S152 was mutated to alanine was generated; reactivity of the TRBP-B band with 
anti-phospho-TRBP antibody was abolished in cells expressing TRBP-B S152A 
(Figure 2E,S2C).  In TRBP KO TEFs co-expressing FL-Lin28a and either myc-
TRBP-B or phosphomutant myc-TRBP-B-S152A (at similar levels, Figure S2B), 
TRBP-B or TRBP-B S152A expression could each produce some basal Lin28a 
elevation, but cells expressing TRBP-B S152A were unable to respond to PMA 
(Figure 2F).  PMA produced a modest Lin28a induction in the absence of TRBP-
31 
 
B expression, an effect which might be due to direct Lin28a phosphorylation 
(Tsanov et al., 2017, Liu et al., 2017) or an alternative unknown interacting 
protein. Collectively, these experiments indicate that the TRBP-B region is 
sufficient to bind and elevate Lin28a protein levels, and support a role for TRBP 
S152 in transducing MAPK pathway activation through TRBP to regulate Lin28a.  
 
Lin28a-3, a truncation sufficient to bind to TRBP 
 To address which region of Lin28a protein interacted with TRBP, we 
generated three domain-based truncations of Lin28a (Figure 3A). Since Lin28b, a 
paralog with 86% amino acid identity between Lin28A amino acid 19 and 177, 
fails to bind to TRBP (Amen et al., 2017), we reasoned that amino acid 
sequences unique to Lin28a at the amino- or the carboxyl- terminus of the 
protein might participate in TRBP interaction. Truncations were designed to 
correspond to functional domains of Lin28a revealed by its crystal structure (Nam 
et al., 2011, Mayr et al., 2013). Lin28a-1, aa 1-112, included the structurally 
uncharacterized N-terminus and the cold-shock domain (CSD). Lin28a-2, aa 75-
154, encompassed half of the CSD, extending to the end of the CCHC Zn 
knuckles.  Lin28a-3 began at the N-terminus of the CCHC, extending to the 
structurally uncharacterized C-terminus of the protein (Figure 3A). 
Full-length FL-Lin28a and FL-Lin28a-3 levels were each elevated above 
baseline by myc TRBP co-expression in 293T cells (Figure 3B-C).  In some 
experimental replicates, we observed mild increases in FL-Lin28a-1 by TRBP.  
We tested whether, like full length FL-Lin28a, either FL-Lin28a-1 or FL-Lin28a-3 
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could be elevated by treatment with PMA (24 hours) in 293T cells co-expressing 
TRBP-B.  FL-Lin28a-1 was not significantly changed either with TRBP-B alone or 
with TRBP-B plus PMA, while FL-Lin28a-3 levels were robustly increased by 
TRBP-B expression and further enhanced by PMA treatment (Figure 3E,F). 
 
Lin28a-3 binds to TRBP-B in a phosphorylation-inducible manner 
The identification of Lin28a-3 and TRBP-B as interacting truncated 
proteins which reproduce the induction observed with full length TRBP and 
Lin28a proteins, presented an opportunity to create a physiological sensor for 
this pathway.  We assayed FRET efficiency between TRBP constructs tagged 
with the CFP variant, Cerulean, and Lin28a constructs tagged with a circular 
permutation of the Venus YFP, cpVenusE172.  FRET was measured in living 
293T cells by bleaching the FRET acceptor, YFP, and measuring dequenching of 
the donor, CFP.  As a benchmark for high FRET efficiency in our imaging 
system, we used a FRET sensor for calmodulin (Figure S3A) (Romoser et al., 
1997). We confirmed YFP bleaching to 75% or greater reduction of signal in each 
cell (Figure S3B-D).  
We tested full-length TRBP and each truncation against a panel of YFP-
tagged Lin28a constructs coexpressed in 293T cells. When coexpressed with 
full-length TRBP, both Lin28a-1 and Lin28a-3 showed non-zero FRET efficiency, 
indicative of significant interaction (Figure 4A).  In congruence with our previous 
findings, FRET efficiency of Lin28a-3-YFP with CFP-TRBP was highest, followed 
by Lin28a-1-YFP, with no FRET between Lin28a-2-YFP and CFP-TRBP (Figure 
33 
 
4A). Consistent with its failure to elevate Lin28a protein levels, TRBP-A displayed 
no FRET-detectable interaction with any Lin28a-YFP truncation (Figure 4B).  In 
contrast, TRBP-B showed significant CFP recovery when coexpressed with 
Lin28a-1-YFP, Lin28a-3-YFP, or full length Lin28a-YFP (Figure 4C). We noted 
that full length Lin28a, which is capable of direct binding to TRBP (Amen et al., 
2017), did not show significant CFP recovery after photobleaching (Figure 4A). 
This is consistent with a risk of false negative results from FRET analyses based 
on fluorophore orientation (Miyawaki, 2011).  Based on these results, we 
concluded that TRBP-B can interact with Lin28a-3, and also to a lesser degree 
with Lin28a-1.  Further, observed FRET efficiency of the Lin28a-3-YFP and CFP-
TRBP-B was higher than that between full length Lin28a and TRBP, suggesting 
that the truncated constructs produce a preferred conformation for a FRET 
biosensor. 
To determine whether TRBP binding by Lin28a-1 or Lin28a-3 could be 
increased by phosphorylation, we treated 293T cells expressing CFP-TRBP-B 
and either Lin28a-1-YFP or Lin28a-3-YFP with either epidermal growth factor 
(EGF, a MAPK pathway activator) or vehicle and measured donor dequenching 
60 minutes after treatment (Figure 4D). FRET between CFP-TRBP-B and 
Lin28a-3-YFP increased significantly after EGF treatment (Figure 4D), consistent 
with the stimulus-dependent increase in protein levels observed in Figure 3E and 
F.  In contrast, EGF treatment did not alter FRET efficiency of Lin28a-1-YFP and 
CFP-TRBP-B.  Notably, there was no detectable FRET between Lin28a-3-YFP 
and the S152A phosphomutant CFP-TRBP-B S152A, indicating a critical role for 
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this serine residue in interaction of the Lin28a/TRBP FRET sensor (Figure 4E).  
In cells treated with EGF for variable time prior to acceptor bleaching, CFP-
TRBP-B and Lin28a-3-YFP demonstrated a time-dependent increase in FRET 
with a maximal plateau by 60-90 minutes (Figure 4E). This corresponded with a 
similar time-dependent increase in the ratio of phosphorylated TRBP-B to total 
myc-TRBP-B observed by immunoblot after EGF treatment (Figure 4F-G).  
 
Optimization and validation of a sensor for Lin28a/TRBP binding 
 Based on the observation that FRET between TRBP-B and Lin28a-3 was 
increased within 90 minutes by EGF, and absent with phosphomutant TRBP-B, 
we performed time-lapse experiments to characterize the stimulation kinetics in 
more detail. We expressed CFP-TRBP-B and Lin28a-3-YFP, in 293T cells and 
calculated the ratio of sensitized YFP fluorescence emission, determined using 
the NFRET formula, to CFP fluorescence (Xia & Liu, 2001). Baseline emission 
ratios were measured in individual cells for ten minutes, followed by imaging for 
thirty-five minutes after EGF treatment. Under these conditions, EGF induced a 
modest average change in NFRET (Figure 5A,B, “Cer/E172”), indicating that 
further optimization would be required to generate a more useful sensor for 
TRBP-Lin28a interaction. To enhance the dynamic range of the sensor, we 
tested a panel of FRET pairs, a strategy that has improved previous sensors 
(Zhou et al., 2015) (Figure 5A). Optimization resulted in a marked improvement, 
with the new FRET pair showing higher average response to EGF (Figure 5B, 
“Cer3/L194”).  We tested the dependence of the Cer3/L194 Lin28a/TRBP FRET 
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sensor on MEK activity. Consistent with previous Lin28a/TRBP interactions, MEK 
inhibition with U0126 (30 min) blocked EGF-induced NFRET increases, while 
293T cells pretreated with vehicle retained an EGF-stimulated increase in 
NFRET (Figure 5C).  
 To investigate the temporal relationship between Erk activation and 
Lin28a/TRBP binding, we co-expressed an intensitometric Erk activity sensor 
(EKAR) based on dimerization dependent RFP (Ding et al., 2015) with the 
optimized Lin28a/TRBP sensor. The spectral separation between 
Cerulean3/Venus and RFP permitted us to monitor signal-induced changes in 
single cells at these two different steps within the EGF response pathway. 
Representative images of cells before and for 80 minutes after EGF treatment 
are shown in Figure 5D. Consistent with our earlier demonstration that S152A 
TRBP-B failed to show detectable FRET with Lin28a-3, we observed that 
NFRET/CFP ratio between the phosphomutant and Lin28a-3 did not increase 
after EGF treatment, even though EKAR activity indicated rapidly peaking Erk 
activation (Figure 5E). In contrast, 293T cells expressing the sensor using WT-
TRBP-B demonstrated NFRET response to EGF (Figure 5F).  Erk activity 
reached a plateau within 15 minutes of EGF on average, and remained at peak 
activity for the duration of imaging (Figure 5F, red curve). The NFRET signal from 
the optimized Lin28a/TRBP sensor increased more gradually, showing slower 
kinetics than Erk activity (Figure 5F, black curve). This slower Lin28a/TRBP 
FRET response compared to EKAR was reproduced in cells treated with PMA 
(Figure S5A-B). We noted that cells with stronger EKAR response also showed 
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greater increases in Lin28a/TRBP NFRET, and analyzed the correlation between 
response magnitudes of the two signals.  Comparing the increase in EKAR 
intensity at 30 minutes of EGF, to the increase of NFRET at the same timepoint, 
we observed a positive correlation between these two readouts (Figure 5G). We 
conclude that this sensor is a reliable tool for imaging ongoing changes in 
Lin28a/TRBP binding in real time within cells, and enables visualization of 
variability and temporal dynamics in signal-dependent events that regulate 
miRNA biogenesis. 
 
Use of the sensor in neurons. 
We were interested in the mechanism for BDNF-induced let-7 
downregulation, and wondered whether it might reflect stabilization of Lin28a 
through localized phosphorylation and TRBP binding (Huang & Ruiz et al, Amen 
et al). Measuring FRET based on acceptor photobleaching would allow us to 
image lin28a/TRBP binding at high resolution in these dendritic structures. We 
expressed the sensor and mCherry in hippocampal pyramidal neurons (2.6a) and 
selected regions of interest in spiny apical dendrites. By confocally imaging the 
recovery of the FRET acceptor, TRBP-B, in hippocampal dendrites treated with 
BDNF for 30 minutes, we observed no higher FRET efficiency on average in the 
WT than the S152A sensor even though EKAR, a positive control, showed fairly 
high FRET efficiency (2.6b). We hypothesized that this might be driven by high 
basal differences in expression level between neurons, and so tried a different 
approach, observing FRET efficiency in paired dendrites from the same neuron 
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before and after 30 minutes of EGF treatment. In one cell out of four examined 
expressing the WT sensor, FRET efficiency increased approximately sixfold. In 
the aggregate, however, no significant difference was observed between FRET 
efficiency before and after treatment in cells expressing either the WT or S152A 
sensor. The EKAR positive control showed a significant FRET effect, indicating 
that BDNF treatment was effective and imaging conditions were appropriate for 
observing a change in FRET (2.6c). 
 
Unimolecular sensor cloning and validation  
 Given that binding between overexpressed lin28a and endogenous TRBP 
has been observed in hippocampal neurons (Amen et al., 2017), we 
hypothesized that the null FRET result in these cells might result from our 
specific experimental conditions. In particular, low FRET could be partly driven by 
differences in expression and localization of the two sensor components. The 
CFP-tagged TRBP-B component, especially, reached distal dendrites and 
dendritic spines at much lower efficiency than the YFP-tagged lin28a-3 
component (figure 2.6a). To drive congruent localization, we generated a 
unimolecular version of the lin28a/TRBP sensor. By Western blot, we observed 
an increase in phosphorylation of the unimolecular sensor after EGF treatment 
(figure 2.6d). By confocal measurement of FRET efficiency in untreated or EGF-
treated HEK 293T cells, the unimolecular sensor showed a smaller dynamic 
range, compared to the bimolecular sensor (figure 2.6e). Higher basal FRET and 
lower absolute changes in response to treatment are expected from a transition 
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from bimolecular to intramolecular FRET sensor format; see chapter 4. Validation 
of the unimolecular sensor in non-neuronal cells is ongoing. 
 
Discussion 
 Signal-responsive regulation of miRNA biogenesis factors allows rapid 
changes to miRNA content in different cellular and signaling contexts (Baek et 
al., 2008, Selbach et al., 2008). In this work, we dissected a MAPK-dependent 
mechanism for enhanced binding between two miRNA binding proteins, Lin28a 
and TRBP, believed to modulate miRNA biogenesis in synaptic plasticity (Huang 
& Ruiz et al., 2012, Amen et al., 2017).  We found that a middle region of TRBP 
(amino acids 98-234, TRBP-B), containing the second dsRBM, was sufficient to 
bind and elevate levels of Lin28a protein in a manner indistinguishable from full 
length TRBP.  Expression of another TRBP truncation containing this same 
middle region (TRBP-AB) also increased Lin28a protein levels (Figure 1E, 1F), 
while truncations lacking this region did not. Interestingly, the Dicer binding 
domain of TRBP covers the third dsRBM located at the carboxyl-terminus of 
TRBP (Daniels et al., 2009, Wilson et al., 2015), perhaps enabling simultaneous 
association of full length TRBP with both Dicer and Lin28a as has been 
previously demonstrated (Amen et al., 2017).  A structural model of TRBP in 
complex with Dicer (Wilson et al., 2015) supports the premise that the TRBP-B 
region may remain available to interact with other binding partners, such as 
Lin28a, when TRBP is bound to Dicer.  
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Of the three domain-based Lin28a truncations tested only Lin28a-3, which 
begins at the CCHC zinc knuckles and terminates at the C terminus of the 
protein, exhibited elevated protein levels when co-expressed with full length 
TRBP or with TRBP-B (Figure 3B, 3D).  Further, only the Lin28a-3 truncation 
exhibited signal-induced elevation in cells co-expressing TRBP-B. While FRET 
pairs containing either the amino-terminal Lin28a truncation (Lin28a-1) or Lin28a-
3 with TRBP-B exhibited FRET, FRET with Lin28a-3 was strongest FRET at 
baseline and capable of stimulus-mediated FRET increase (Figure 4).  Low basal 
FRET between Lin28a-1 and TRBP-B could occur due to a secondary interface 
between the two proteins. These data suggest that the C terminal Lin28a-3 
truncation contains a minimal unit for signal-inducible binding to TRBP. Since full 
length Lin28a can co-associate with TRBP, while the highly homologous Lin28b 
does not, (Amen et al. 2017), we suspected that the signal-inducible binding 
region of Lin28a might share scant homology with Lin28b; this is true for the C-
terminal ~20 amino acids of Lin28a-3.  
We identified a role for TRBP phosphorylation at serine 152, an ERK 
consensus site proximal to a putative ERK docking site, in enhancing Lin28a 
interactions after cellular MAPK pathway activation with EGF or PMA.  While 
phospho-mutant TRBP-B S152A remained able to stabilize full-length Lin28a 
over baseline (Figure 2d,f), it was unable to participate in signal-enhanced 
elevation of Lin28a protein or FRET efficiency.  Likewise, a full length phospho-
mutant TRBP, with 4 S-to-A mutations including S152A, retains a weakened 
basal co-association with full length Lin28a (Amen et al., 2017). These findings 
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highlight a role for TRBP S152 in signal-dependent enhancement of TRBP-
Lin28a interactions and induction of Lin28a protein.  The dsRBMs of TRBP, 
including the motif within TRBP-B, participate in binding to other proteins, most 
notably PACT and PKR (Daher et al., 2001, Laraki et al., 2008), and could also 
play a role in basal binding to Lin28a.  
 The Lin28a/TRBP FRET sensor leverages the utility of FRET imaging 
approaches for probing complex protein/protein interactions to provide 
spatiotemporal information about specific binding interactions. We observed that 
FRET signal, indicative of Lin28a and TRBP binding, exhibited slower kinetics 
relative to Erk phosphorylation read out from the EKAR sensor.  We did not find a 
condition that induced return of the FRET signal to baseline levels, suggesting 
that signal-induced binding of sensor may persist despite dephosphorylation, or 
that the truncation constructs included in the sensor lack a sequence involved in 
dissociation or dephosphorylation. The TRBP literature implicates multiple 
proline-dependent MAPKs, chiefly Erk and JNK, in TRBP regulation (Warner et 
al., 2016, Chen et al., 2015; Kim et al., 2014), including additional residues within 
TRBP-B. This FRET sensor may be of future use in probing the function of these 
phosphoregulatory sites, as well as investigation of compartmentalized TRBP 
and Lin28a interactions in a variety of physiological contexts. For example, both 
TRBP and Lin28a have roles in protein translation and silencing in the peri-
endoplasmic reticulum region (Stalder et al., 2013, Cho et al. 2012).  
We had hoped that the sensor could be used to gain spatio-temporal 
information regarding TRBP interaction with Lin28a occurring downstream of 
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neurotrophins, which may exert effects on synaptic plasticity and protein 
synthesis in a variety of neuronal compartments. However, unpublished data 
establishing Lin28a upregulation in neurons have been difficult to validate, and 
preliminary experiments with the sensor suggest that, if TRBP/Lin28a interaction 




Materials & Methods  
Cloning 
 TRBP truncations (as published (Daher et al., 2001) were N-terminally 
tagged with myc (MEEQKLISEEDL), or fluorescent proteins Cerulean (Rizzo et 
al., 2004), Cerulean-3 (Markwadt et al., 2011), or ECFP (Llopis et al., 1998). 
Lin28a truncations were derived from FL-Lin28a (Amen et al. 2017) by PCR and 
tagged with flag (DLYDDDKD) at the N terminus or YFP variants Venus (Nagai et 
al 2002), Citrine (Griesbeck et al., 2001), cpVenus-E172 and cpVenus-L194 
(Nagai et al 2004) at the C terminus. Phosphomimic and phosphomutant 
versions of all TRBP and Lin28a constructs were derived from wild-type versions 
of these constructs, using a QuickChange kit (Agilent) per manufacturer 




HEK 293T cells were cultured and transfected as described (Amen et al., 
2017).  When multiple truncations of the same protein were expressed for the 
same experiment, transfection levels were optimized to equalize affinity tag level 
in lysates from different truncations. Total DNA transfected was equalized 
between conditions using empty pcDNA vector. Mouse tail epithelial fibroblast 
cells (TEFs) lacking endogenous murine TRBP (Tarbp2 KO) (gift of A.Gatignol, 
(Daher et al., 2009)) were cultured in DMEM with 10% FBS supplemented with 
penicillin and streptomycin. Cells were seeded at 15,000 cells per well in 24-well 
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Cultured cells were washed in cold PBS and harvested on ice with lysis 
buffer (50 mM HEPES, 150 mM NaCl, 10%Glycerol, 1 mM EDTA, 1% Triton X-
100, 0.2% SDS) plus protease inhibitor cocktail (Roche 11836170001), and 
phosphataseinhibitors (sodium orthovanadate 0.2 mM, sodium pyrophosphate 1 
mM). Protein concentration was determined by Bicinchoninic acid (BCA) assay 
and equal protein amounts resolved on SDS-PAGE gels and electrotransferred 
to PVDF membrane. Membrane was blocked with 5% BSA in Tris-buffered saline 
tween 20 (TBST 0.1%) for 1-3 hr and probed with primary antibodies: c-Myc 
(Lifetech 132500), FLAG (Sigma M2, F3165) TRBP (Abcam ab72110,or 
Proteintech 15753-1-AP), Phospho-TRBP (custom), Hsc70 (Santa Cruz sc7298) 
All immunoblots were scanned and quantified without image adjustment. For 
representative image figures, image levels were uniformly and minimally adjusted 
for visual clarity in some instances. 
 
Immunoprecipitation  
For FL-Lin28a co-immunoprecipitation of TRBP and its truncations, mouse 
anti-flag M2 antibody (Sigma) was adhered to protein G sepharose beads 
overnight after blocking with 5% BSA for 1 hour. HEK 293T cells coexpressing 
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the constructs of interest were harvested in coIP lysis buffer (100 mM KCl, 4 mM 
MgCl2, 10 mM HEPES (pH 7.3), 50 uM ZnCl2, 0.5% NP-40) with protease 
inhibitor cocktail (Roche), and phosphatase inhibitors (Sigma, phosphatase 
inhibitor cocktail 2 and 3).  Insoluble material was first removed by centrifugation 
(10,000 g) and lysates pre-cleared by rotation (4 °C, 1 hr) with unblocked 
sepharose beads. Equal masses of protein in pre-cleared lysates were brought to 
equal volume, added to flag antibody-coated beads, and rotated (4 °C, 3-4 hr).  
After washing 3x with coIP wash buffer (150 mM NaCl, 1 mM MgCl2, 50 mM 
HEPES (pH 7.8), 50 uM ZnCl2, 0.05% NP-40), immunoprecipitated material was 
eluted at room temperature using 1x flag peptide (Sigma F3290) diluted in coIP 
wash buffer. 
 
Epifluorescence Imaging:  
 Live cell fluorescence and FRET imaging were conducted on a Zeiss 
Axiovert 200M microscope controlled by Metafluor 6.2 software. Cells seeded on 
poly(L)lysine coated glass-bottom imaging dishes (MatTek Corporation) were 
incubated at 37 C in Hank’s Balanced Salt Solution (HBSS), and imaged at 40x 
magnification with 50% neutral density filters, illuminated by an arc lamp and 
captured on a cooled charge coupled device (Photometrics). Fluorescence 
emission was collected from cyan fluorescent protein (420DF20 excitation filter, 
500 ms excitation, 475DF40 emission filter); yellow fluorescent protein (420DF20 
excitation for 50 ms, 535df25 emission filter); sensitized YFP emission (CFP 
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excitation and YFP emission); and red fluorescent protein (568DF55 excitation 
filter, 50ms, 600DRLP dichroic mirror, 653DF95 emission filter). 
 For endpoint FRET imaging, cells expressing CFP-tagged TRBP or a 
truncation and YFP-tagged lin28a or a truncation were serum starved for 
approximately fifteen minutes in imaging media. Several images were taken to 
establish a baseline, followed by 90 second, 3 minute and 5 minute illumination 
at 504 nm to bleach YFP. Images were quantified using MetaFluor 6.2 software 
(Universal Imaging). FRET efficiency was calculated based on the recovery in 
background-corrected CFP brightness after YFP bleaching, using the following 
formula:  
FRET efficiency = 1-Fda/Fd 
 where Fda is the CFP fluorescence observed when both donor and acceptor are 
active, and Fd,is the fluorescence observed after YFP photobleaching. To confirm 
complete photobleaching, percent change in YFP intensity was calculated, using 
the formula: 
% photobleaching = [(intensity final-intensity initial)/intensity initial] * 100% 
Only dishes with an average reduction of 80% or more in YFP signal were used 
for FRET efficiency calculation in epifluorescence experiments. 
For time-course FRET imaging, cells expressing CFP-tagged TRBP-B 
with YFP-tagged Lin28a-3 were serum starved (0.5-2 hrs) in imaging media, then 
imaged every 30 s. CYFRET, CFP, YFP and RFP intensity in each ROI were 
measured over time using MetaFluor software and, after background subtraction, 
used to calculate the normalized FRET emission ratio, a measure that adjusts for 
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expression level and spectral bleedthrough of donor and acceptor fluorophores 
(Xia & Liu, 2001).  
NFRET = FRET intensity – [YFP intensity x a] – [CFP intensity x b] 
NFRET ratio = NFRET/CFP 
Bleedthrough value “a” was determined using cells expressing only YFP, 
then imaged in both the CYFRET and YFP channels. “A” was defined as the 
signal in the YFRET channel as a percent of YFP signal; on this system, the 
value used was 0.14. Bleedthrough value “b” was calculated using the same 
approach with CFP alone, and came to 0.32. Representative images shown in 
figure 5E have had NFRET value calculated using the Image Calculator function 
in ImageJ to perform the same series of calculations  (i.e., mean background 
subtraction in each channel, followed by subtraction of estimated bleedthrough 
from CFP and YFP direct channels, applied to CYFRET channel).  
 
Statistical analyses 
 All quantified data represent mean +/- SEM. Statistical analysis included 
one-way ANOVA for independent samples with a Bonferroni post hoc test, α = 
0.05, comparing to Lin28a alone or comparable condition. Where noted, two-
tailed student’s t tests were used for pairwise comparison of untreated and 
treated conditions (Figure 2C, 2F). Linear regression analysis and slope 
significance testing were carried out using a Graphpad Prism protocol equivalent 
to ANCOVA.  Before linear regression was performed, independent variables 
were subjected to a Grubb’s test with α = 0.05. The result was used to justify 
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Figure 1. A TRBP truncation sufficient to bind and elevate Lin28a levels. (A) Domain map of 
TRBP, with truncations TRBP A, B, C and TRBP AB. Phosphorylation sites (pink) as described 
(Paroo et al., 2009) (B,C) TRBP A and B stabilize FL-Lin28a in 293T cells (n=7-14) (D) Increase 
in endogenous TRBP level with TRBP truncation vs. Lin28a alone (n=5-8) (E,F) Full length TRBP 
and TRBP B, but not TRBP A, elevate Lin28a levels from baseline in Tarbp2-/- MEF cells (n=9) 
(G) Regression analysis on the effect of expression level of full length TRBP, TRBP A, or TRBP B 
on FL-Lin28a, in Tarbp2-/- cells, plotted relative to FL-Lin28a plus empty vector. The regression 
line for TRBP full has a correlation coefficient (r) of 0.51 (p=0.114 for deviation from zero slope). 
One statistically significant outlier was removed (Methods). Myc TRBP A regression r=0.06 
(p=0.638) and Myc TRBP B regression r=0.62 (p=0.06) (H) Coimmunoprecipitation of FL-Lin28a 




Figure 2. TRBP-B phosphorylation at S152 enhances binding to Lin28a. (A) Putative ERK 
substrate sequence of TRBP at serine 152, including FSP docking site. Weaker candidate ERK 
substrate at serine 142 (B) Immunoblot from 293T cells expressing TRBP-B shows two or more 
phosphorylated species exist and can be collapsed by lysate treatment with lambda phosphatase. 
(C,D) Representative blot and quantitation showing levels of FL-Lin28a, phospho-TRBP and myc-
TRBP-B proteins from 293T cells pretreated with U0126 (20 uM), with or without PMA treatment 
(50 ng/mL) (n=15) (E,F) Representative blot and quantitation showing effect of PMA on FL-
Lin28a level in Tarbp2-/- MEF cells coexpressing TRBP-WT or S152A and treated with PMA 
(n=8) (D,F) # p<0.05, ANOVA; * p<0.05, paired t-test.  
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Figure 3. A C-terminal Lin28a truncation sufficient to respond to TRBP and TRBP-B. (A) 
Domain map of Lin28a, with truncations Lin28a-1, 2 and 3. (B,C) Coexpression of FL-Lin28a and 
truncations with full length TRBP in 293T cells increases Lin28a and Lin28a-3. (* p<0.05, 
ANOVA, n=4) (D-F) Effect of coexpression of TRBP-B and treatment with PMA on protein level of 
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FL-Lin28a-1 (D) and FL-Lin28a-3 (E). (* p<0.01, two-way ANOVA, n=3-5) (G-H) Effect of 
coexpression of TRBP-B on WT or S200A mutant of FL-Lin28a-3 (* p<0.05, ANOVA, n=9) 
 
 
Figure 4. Lin28a-3 interacts with TRBP-B in a phosphorylation inducible manner. (A) FRET 
efficiency of C-terminal cpVenusE172-tagged Lin28a and truncations with full-length N-terminal 
Cerulean3-tagged TRBP (B-C) FRET efficiency of Lin28a and truncations with TRBP-A and B. 
(A-C) *p<0.05 vs. 0, t test (D) FRET efficiency of Lin28a-1 and 3 with TRBP-B after treatment with 
100 ng/mL EGF for 60 minutes. (E) FRET efficiency of Lin28a-3 with TRBP-B after EGF 
treatment. “S152A” indicates efficiency of Lin28a-3 with phosphomutant TRBP-S152A (D-E, * 
p<0.05 vs. untreated, ANOVA) (A-E) n=15-75 cells per column from at least two dishes. (F, G) 
Increase in phospho-TRBP-B, measured by immunoblot, after EGF treatment. (#p<0.05, ANOVA, 






Figure 5. Optimization of a sensor for phosphorylation-induced Lin28a/TRBP binding. (A) 
Qualitative assessment of Lin28a/TRBP FRET pairs, scored based on flat baseline and 
magnitude of response (n=2-6 dishes/pair). (B) Comparison of NFRET ratio change, normalized 
to T0, between representative 293T cells expressing sensor with original FRET pair (“Cer/E172”) 
or optimized sensor (“Cer3/L194”) after EGF treatment. (C) Optimized sensor FRET response to 
EGF in 293T cells pretreated with vehicle (red) or U0126 (blue) (n=4 cells per condition). (D) 
Pseudocolor image series of Cer3/L194 sensor signal (“NFRET”) and EKAR sensor intensity 
(“RFP”) in 293T cells pretreated with DMSO and then treated with EGF. (E-F) Representative 
curves showing change in NFRET (black) coimaged with increase in Erk activity (red) in response 
to EGF in cells expressing S152A sensor (E, n=7) or WT sensor (F, n=6) (G) Regression analysis 
of EKAR intensity change and NFRET intensity change, measured 30 minutes after EGF 




Figure 6. Toward neuronal imaging of Lin28a/TRBP interaction. (A) Representative images of 
a hippocampal pyramidal neuron coexpressing Cerulean-TRBP-B (CFP), Lin28a-3-L194 (YFP), 
and mCherry filler. Note restricted CFP distribution. (B) FRET efficiency in hippocampal pyramidal 
neurons expressing CFP alone, WT sensor, S152A sensor, or EKAR, treated with BDNF for one 
hour prior to photobleaching. (C) FRET efficiency in paired dendrites from single neurons before 
and after 30m BDNF treatment. (D) Increase in TRBP phosphorylation relative to GFP in 
unimolecular sensor after 30m EGF treatment. (E) FRET efficiency in 293T cells expressing 








Figure S1. Increasing Lin28a transfected reduces fold stabilization by TRBP. (A) 
Overexposure of lysates expressing myc TRBP A, B and C, showing weak myc TRBP C signal. 
(B-C) Effect of expression of equal amounts of TRBP A or B on the stability of 5, 25 or 50 ng of 
transfected Lin28a in 293T cells (n=3-5) 
 
Figure S2. TRBP-B phosphorylation level in Tarbp2-/- MEF cells. (A) Validation of p-TRBP 
S152 antibody using phosphatase-treated lysates expressing myc TRBP B, as in Figure 2B. (B-
C) Related to Figure 2E-F. Quantitation of level of myc TRBP-B (n=6-8) (C) and phospho TRBP-
B S152 (n=9) (B) in Tarbp2-/- cells expressing FL-Lin28a and a WT or S152A TRBP-B, treated 




Figure S3. Comparable YFP photobleaching across FRET efficiency experiments. (A) FRET 
efficiency of a positive control construct, FIP, compared to Lin28a-3 + TRBP B (Romoser et al., 
1997) (B-D) Percent reduction in YFP intensity in photobleaching experiments using full-length 
CFP-tagged TRBP (B), TRBP A (C), and TRBP B (D). Comparable YFP reduction was attained 
across all construct pairs. N=15-75 cells per column, from at least two independent dishes. 
 
Figure S4. Supporting data from FRET sensor development. (A) Representative curves 
showing response of Lin28a/TRBP sensor (gray) and EKAR (red) in a single cell treated with 
PMA. (B) Average normalized change in Erk activity and NFRET/CFP ratio in cells treated with 




Chapter 3: Genetically encoded fluorescent biosensors for live-




From the first use of fluorescently-tagged antibodies to image fixed cells 
through the present, scientists have wanted to visualize and thus better 
understand various molecular systems inside the cell.  One tool that has gained 
traction for real-time analysis of these systems is the fluorescence-based, 
genetically encodable biosensor.  
Early optical sensors included small molecules that bound to analytes, 
such as fura2 to calcium (Williams et al., 1985).  Expanding the scope of 
biosensors to detect targets that are not easily bound by small molecules, a 
cAMP probe was developed in 1985 based on the dissociation of the catalytic 
and regulatory subunits of protein kinase A (PKA) when the kinase is activated 
(Adams et al., 1991). The two subunits were purified separately, tagged with the 
fluorophores rhodamine and fluorescein, and finally reintroduced to cells by 
microinjection. The dissociation of the subunits when cAMP was present caused 
a change in energy transfer between the two fluorophores, enabling visualization 
of where and when cAMP was produced for the first time. However, the probe 
was labor-intensive to produce and cumbersome to introduce into cells.  
The advent of GFP and other fluorescent proteins solved both of these 
difficulties at once, and has inspired subsequent decades of optical probe design. 
Fluorescent proteins have proven to be a good tool for measuring in-cell activity 
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because they are genetically encodable, bright, and available in many colors, 
enabling monitoring more than one target. Their genetic encodability is especially 
desirable in order to take advantage of the cell's own protein-synthesis 
machinery, introduce fluorophores with minimal disruption to the cell, and target 
probes to subcellular regions of interest. Furthermore, fluorescent proteins, 
having evolved in a cellular environment and been extensively engineered for 
use in mammalian cells, are compatible with cellular pHs, redox properties, and 
other characteristics. 
After early development of genetically encoded reporters for calcium 
(Miyawaki et al., 1997) and cAMP (Zaccolo et al., 2000), a wide range of 
biosensors has been developed for monitoring different cellular events. Sensors 
for changes in pH and redox state; accumulation of second messengers; and 
activation of enzymes like kinases and phosphatases have all been reported. 
Kinases constitute a key class of signaling proteins, mediating information flow 
between external and internal environments or between subcellular 
compartments. Because of the broad reach of each activated kinase and the 
complex signaling cascades that lead to its activation, many kinases are key 
nodes in cell signaling networks.  
This chapter aims to introduce the reader to biosensor development and 
application, focusing on those developed for kinases and their upstream second 
messengers. In the effort to understand signaling as it occurs in vivo, non-
destructive technologies for monitoring signaling over time are required; 
biosensors are uniquely positioned to fill this need. In recent years, kinase 
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activity reporters have been used to address a variety of systems-level questions 
in increasingly complex model systems.  
In their conception and optimization, in-cell fluorescent biosensors have a 
great deal in common with development of small-molecule probes. Like such 
probes, genetically encodable biosensors are used for studies of basic biology 
and also to investigate the activities of many different disease-relevant signaling 
pathways. These tools are effort-intensive in terms of conception, development 
and optimization; however, the resulting benefit of these tools especially in 
furthering our understanding of signaling biology outweigh the costs associated 
with the design process. Like any good technological product, probes are subject 
to quality control and are often modified based on user feedback. Thus, we 
introduce the "pipeline" of biosensor development and application (see figure 1). 
We will begin by addressing some common considerations and frequently-used 
blueprints for biosensor design, then report as a case study the ongoing effort to 
develop a sensor for I kappa B kinse (IKK). We will conclude with considerations 
for the use of biosensors once they are developed, and the outlook of the field as 
a whole. 
  
Biosensors: the pipeline  
 
Genetically encodable probes 
The general blueprint for a kinase/second messenger biosensor includes 
a sensing unit that senses the change of interest, and a reporting unit to indicate 
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the sensing unit’s state. To visualize a signaling event of interest, the designer of 
a sensor often needs to identify or engineer a molecular switch wherein a change 
in conformation occurs in response to signaling. The reporting unit typically 
contains one or more fluorescent proteins. A wide variety of genetically 
encodable kinase activity biosensors and second messenger indicators have 
been developed along these lines (summarized in table 1). 
 
Sensing  
 One approach to generating a molecular switch is to regard the cell as a 
molecular toolkit—the approach used in developing the first PKA-based sensor 
for cAMP. The switch can be a protein or protein fragment that changes its 
conformation upon binding to a second messenger molecule; or it may change 
conformation after being enzymatically modified by the signaling enzyme of 
interest.  Probes designed along these lines include a FRET-based sensor for 
the conformational change of NFAT after dephosphorylation by calcineurin 
(Newman et al., 2008) and a split-luciferase sensor for activity-related 
conformational changes in Abl kinase (Zhou et al., 2009). 
If no suitable change occurs within one protein, the designer may 
repurpose domains from several proteins to develop an engineered switch. In the 
case of a kinase activity reporter, for example, a common blueprint involves the 
consensus substrate sequence, separated by a linker from a phospho amino acid 
binding domain that binds to that sequence when it is phosphorylated. The 
phospho amino-acid binding domain (often designated PAABD in schematic 
60 
 
diagrams) is usually adapted from a conserved domain such as the 14,3,3 
proteins; forkhead-associated (FHA) domain; two-tryptophan (WW) domain; or 
Src homology (SH2) domain. Sensors for activity of PKA (Zhang et al., 2001), 
Erk (Harvey et al., 2008), and a wide variety of other kinases use this scheme.  
Switches derived from two endogenous proteins may also be left 
separate, in order to form a bimolecular sensor. The bimolecular sensor class is 
quite large and includes many sensors designed on an ad-hoc basis for studies 
to determine when and where two proteins of interest interact, including 
heteromeric binding of receptors for peptide hormones (Almabouada et al., 
2013), various neurotransmitters (Borroto-Escuela et al., 2012), SNAREs 
(Degtyar et al., 2013) and immune signaling molecules (Hashimoto-Tane et al., 
2010). In addition to providing information about the location and timing of protein 
interactions, bimolecular sensors can be used to determine what portions of the 
proteins are required for interaction (Borroto-Escuela et al., 2012) or to 
characterize the dissociation kinetics of the two proteins (Song et al., 2012).  
Occasionally, to solve problems such as very high basal FRET, sensors 
initially designed in a single-polypeptide unimolecular format have been broken 
into bimolecular sensors by removing the linker to generate two separate 
proteins (Herbst et al., 2011). This modification can yield sensors with greater 
dynamic range, owing to better separation of FRET partners in the “off” state, but 
it can also introduce difficulties in data interpretation. In bimolecular versions of a 
probe, the donor/acceptor stoichiometry is not fixed, which can affect the signal 
(Jares-Erijmen and Jovin, 2003). This added variable requires the experimenter 
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either to ascertain that the two subunits are expressed at equal levels or to use 
one of several correction algorithms that correct for nonhomogeneous subcellular 
distribution or uneven labeling before calculating FRET (Hachet-Haas et al, 2006; 
Deplazes et al, 2012). It has also been observed that bimolecular versions are 
much more sensitive to off-target binding. For example, a bimolecular version of 
the calcium sensor Cameleon was based on calcium induced binding between 
calmodulin and the calmodulin-binding domain of myosin light chain kinase 
(MLCK). The bimolecular version of Cameleon was suggested to have a higher 
tendency to bind to endogenous components (Miyawaki, 2003). In this case, 
even the unimolecular version was influenced by binding of endogenous 
components, showing very low optical activity when endogenous calmodulin was 
abundant. This problem led to an effort to rationally re-engineer calmodulin and 
calmodulin binding peptides that bind to one another and to calcium, but clash 
sterically with endogenous calmodulin, based on a “bump and hole” modification 
of binding surfaces (Palmer et al., 2006). 
If a desired switch cannot be assembled from naturally-occurring proteins 
or domains, it is possible to engineer a switch or part of a switch such as a 
binding domain. For example, in the absence of a strong and specific binding 
protein for phosphorylated IB, which is usually degraded following 
phosphorylation, one group used SELEX, a technique for directed evolution from 
a starting RNA library, to obtain a peptide that bound specifically to phospho- 
IB (Olson et al., 2008). This binding domain was tested in the context of an 
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engineered molecular switch for an activity reporter for IKK (inhibitor of NF-κB 
kinase) and was found to be functional in vitro. 
 The conformational change of the switch can be engineered using 
different designs. For instance, a switch could be engineered using the design of 
a pseudo-ligand, which ideally binds only when the true ligand is absent. For 
example, an Akt-based probe for the presence of 3’ phosphoinositides used the 
pleckstrin homology (PH) domain from Akt, fused with an acidic peptide pseudo-
ligand that bound to the PH domain with low affinity. When phosphoinositides are 
present, the pseudo-ligand is displaced, changing the switch conformation 
(Ananthanarayanan et al, 2007). Based on a similar pseudoligand design, some 
switches are engineered to be a hybrid of genetically encoded and synthetic 
domains. “Snifit” is a transmembrane probe composed of a glutamate receptor 
with two “self-labeling” peptide tags added to the extracellular terminus. These 
peptides can be covalently labeled with fluorescent dyes bearing moieties that 
react specifically with cognate groups on the peptides (Gautier et al., 2008).  In 
the case of Snifit, one synthetic fluorophore and another synthetic fluorophore 
conjugated with a glutamate mimic as the pseudoligand are added to label cells 
expressing Snifit such that FRET occurs between two fluorophores in the 
absence of glutamate. The pseudoligand, however, is displaced by endogenous 
glutamate, resulting in reduced FRET when glutamate is present in the 
extracellular space (Brun et al., 2012). Other synthetic strategies for kinase 





Once a molecular switch is selected, it must be placed within a sensor so 
that its binding or conformational change produces a change in optical 
properties. A number of design principles exist, ranging from simple intensity 
changes to ratiometric methods (see figure 2). Reporting domains may consist of 
one fluorescent protein, two peptides that combine to reconstitute a fluorescent 
or luminescent protein, or two fluorescent proteins. 
 Single fluorescent protein-based biosensors typically use a fluorescent 
protein with its protective beta-barrel broken, engineered so that the 
conformational change of the embedded molecular switch is transduced to also 
change the fluorescent protein’s conformation and allow fluorescence to recover. 
This strategy has been used to create sensors for calcium, including GCAMP 
(Nakai et al., 2001). In one case, it has been used to indicate tyrosine 
phosphorylation (Kawai et al, 2004).  
Bimolecular fragment complementation-based probes, feature two 
complementary fragments of a fluorescent protein, able to fluoresce only if they 
are brought into proximity, or two fragments of luciferase that reconstitute a 
functional luciferase when brought into proximity. These probes have been used 
for analysis of protein/protein interactions and kinase activity (Herbst et al., 
2011); between the two, luciferase fragment complementation is more favorable 
for tracking reversible processes because fluorescent protein complementation is 
irreversible (Rebois et al., 2008).  
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Sensors using two fluorescent proteins typically rely on fluorescence 
resonance energy transfer (FRET). FRET is the non-radiative transfer of energy 
from one fluorophore to another via dipole-dipole interactions, resulting in 
reduced fluorescence from the shorter-wavelength and higher-energy “donor” 
fluorophore and increased emission from the longer-wavelength and lower-
energy “acceptor.” Because FRET is highly distance and orientation dependent, 
with a sharp decrease in efficiency at nanometer-scale distances much shorter 
than the diffraction limit of light, it is a useful biophysical process for sensing 
proximity on a scale too small to be visualized as co-localization.  
Flanking a molecular switch with a fluorescent protein pair competent for 
FRET enables monitoring of the conformation of the switch by the changes in 
FRET. One popular measure is FRET intensity ratio, a ratio of acceptor emission 
to donor emission after excitation at the donor wavelength. In addition to 
intensity, FRET can be measured by donor fluorescence lifetime (Padilla-Parra et 
al, 2012) or fluorescence anisotropy (Piston and Rizzo, 2008); these techniques, 
along with advantages and disadvantages of each, have been reviewed at length 
in the reviews listed above, as well as by Day and Davidson, 2012; Periasamy et 
al., 2008; and Sun et al., 2013.  
 
Biosensor quality control and optimization 
A successful probe needs to be both sensitive to and specific for the 
species of signaling molecule under study. Specificity for the kinase of interest 
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needs to be verified, and the sensitivity and dynamic range of the probe generally 
require empirical optimization.  
Once a probe is developed, and shows a satisfactory change in optical 
properties in response to the signal of interest, it is important to confirm that the 
optical change is specific to that signal. For probes based on kinase substrates, 
generating a quality control to rule out artifactual changes can be as easy as 
mutating the phosphorylated residue of the sensor to ensure that signal changes 
are abolished (Herbst et al., 2011). Another approach, which ensures that 
phosphorylation stems from the kinase of interest, is to stimulate cells expressing 
the kinase biosensor in the presence of an inhibitor specific to the kinase to 
ascertain that no spurious signal is observed (Eisler et al., 2012). The optical 
change may also be compared with traditional biochemical techniques like 
western blotting if phospho- and total protein antibodies are available for the 
target kinase or its substrates (Newman et al., 2008).  
Many phosphorylation reactions are carried out by a large family of related 
kinases with subtly different selectivity and activity; therefore, another 
consideration in a probe’s specificity is whether it is selective to the specific 
enzyme. Kajimoto et al. (2010) specialized a pre-existing protein kinase C (PKC) 
sensor (Violin et al., 2003) based on a consensus PKC phosphorylation site, 
using sequences from PKCδ substrates. When the new probe was expressed 
alongside a panel of FP-tagged PKC isoforms, it responded specifically to PKCδ. 
An alternate approach to enhancing specificity is to add a selectivity-enhancing 
module to the sensor backbone; for example, Fosbrink et al. (2010) generated a 
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probe selective for JNK over Erk1/2 by adding a docking domain to the shared 
substrate sequence. This type of optimization enables investigation of differences 
between closely related but differentially regulated kinases. 
Once specificity has been established, a probe’s sensitivity can be 
characterized using in vitro assays. For example, a dose-response curve 
showing optical changes in response to increasing analyte concentrations can be 
used to determine both dynamic range of the probe, in terms of response 
amplitude, and the concentration range of analyte that can be sensed accurately 
(Tantama et al., 2012). In some cases, this in vitro step is bypassed in the 
development of kinase sensors because of the relative difficulty of purifying 
kinases in their active form; instead, the magnitude of response to a known 
strong stimulant of the kinase is measured. For probes with a low dynamic range 
or small FRET change, only very large changes in kinase or phosphatase activity 
can be detected. Because responses to strong stimuli in cultured cells usually far 
exceed responses to physiological stimuli in vivo, such probes require 
optimization in order to detect subtler changes. Optimization can be carried out 
on a semi-rational basis by tuning various factors that affect the FRET efficiency, 
including orientation of and distance between the two fluorophores. 
Because effective energy transfer depends on alignment at an optimal 
orientation of the two fluorophores, minor changes during the optimization of 
biosensors can lead to unpredictable changes in dynamic range. One common 
strategy for biosensor optimization is to switch between spectrally similar 
fluorescent proteins in order to alter the orientation of the donor and acceptor 
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fluorophores. For example, introduction of circularly permuted Venus, whose N 
and C termini are at different positions relative to the central fluorophore, can be 
a useful strategy to increase the dynamic range of probes (Nagai et al., 2004; 
Allen et al., 2006). 
Distance between the fluorophores can be modulated by changes to the 
length of a peptide linker in a unimolecular sensor, often yielding changes in 
dynamic range. The linkers of unimolecular sensors have been the target of 
extensive optimization efforts. Several groups have worked to optimize a generic 
backbone using a flexible linker, which allows the fluorescent protein pair to 
sample many different orientations and limits signal induced changes to those 
dependent on distance. Although the process of adjusting linker length for 
optimal FRET efficiency takes time, once a suitable linker is found, it may be 
used for different substrate/recognition domain pairs. Komatsu et al. (2011) 
developed a backbone with a flexible 116 amino acid linker that improved the 
dynamic range for a number of kinase and GTPase sensors and was used to 
rapidly develop several new kinase sensors. Ibraheem et al. (2011) used a library 
approach to optimize linker length, comparing basal and maximally-stimulated 
states in replica-plated bacterial colonies. This approach allowed rapid 
assessment of dynamic range in a large number of variants of the probe. An 
alternate approach, especially useful for probes with highly structured 
components, is to rationally design rigid linkers to optimize fluorophore distance 
(Lissandron et al., 2005). 
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However, distance dependency of FRET may not always be easily 
deconvolved from orientation dependency. For example, while developing a 
unimolecular sensor for glutamate based on the conformational change of a 
glutamate-binding protein, one group observed a four-fold change in dynamic 
range between versions that differed in length by only one amino acid (Hires et 
al., 2008). They ascribed this change to the sensitivity of energy transfer to 
minute differences in orientation and distance, which were enhanced by the 
rigidity of the peptide in between the fluorescent proteins. 
Publication to report on the development of a sensor is rarely the final 
word in its optimization (see figure 3.1). Even after a sensor has been introduced, 
updated versions are frequently released. The groups or individuals who 
developed a probe often continue to improve it, while users also adapt probes for 
their needs. In many cases, dynamic range remains relatively small, with 
continued optimization a desirable and ongoing process (Marvin et al, 2013; 
Depry et al., 2011; Kajimoto et al., 2010). Adaptations to prior probes include 
changing optical readouts, for example converting a probe optimized for 
ratiometric FRET for FLIM imaging, (Oliveira and Yasuda, 2013), and reducing 
sensitivity to pH and other off-target variables. Thus, optimization is most 




Sensor expression in primary culture and live animals 
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 The payoff for the lengthy work of biosensor development is the ability to 
use the finished product to address a wide range of questions in many cell types. 
The fundamental question sensors uniquely answer is how various kinases 
function in a cellular context; although antibodies may be available to give insight 
into phosphorylation state, they can provide only snapshots of kinase activity. 
Biosensor approaches offer enhanced spatiotemporal resolution. 
Often the first generation of a sensor is used to inquire into how the kinase 
of interest behaves in a cell line. The use of sensors to better understand such 
signaling has been reviewed extensively (Sipieter et al, 2013; Miyawaki, 2003; 
Mehta et al., 2011).  Briefly put, a novel sensor can be used to explore the role of 
a kinase in cell activities, to study how absence or overexpression of interactors 
affects activity of the kinase, the location of kinase activation, and circuit analysis 
of interacting pathways, among other questions.  
 There are many cell-type-specific processes that are known to involve the 
activity of one or more kinases, but wherein the exact function of the kinase in 
question is incompletely described. In order to get that missing information in a 
more physiologically relevant context, primary cells and live animals are used. 
We will describe in detail how sensors have provided valuable information about 




Biosensor imaging in transgenic animals 
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While most of the biosensor experiments described above were carried 
out in transiently transfected primary cell cultures, studies of PKA in neurons 
have recently become available in a whole-brain context in live, behaving 
animals. One study used a fly line inducibly expressing AKAR, which was imaged 
via two-photon FLIM, to understand why the mutants rutabaga and dunce have 
defects in aversive learning (Gervasi et al., 2010). The authors found that 
rutabaga, a calcium-sensitive adenylyl cyclase, is a coincidence detector for 
octopaminergic and dopaminergic stimuli that are both below threshold levels, 
facilitating associative learning; mutations in rut slowed the accumulation of PKA 
activity. On the other hand, mutations to dunce, a phosphodiesterase, caused a 
slightly higher PKA response than the wild-type; the phosphodiesterase plays a 
role in restriction of dopamine-responsive PKA activity to specific brain regions. 
This is a good example of the potential of kinase and phosphatase studies 
in vivo to further our understanding of the connections between subcellular 
signaling circuits and behavioral output. For translational purposes, mammalian 
systems such as mouse are appealing targets for similar in vivo studies. 
However, there are a number of challenges for in vivo kinase studies, particularly 
in living mice. Because of the propensity of tissue to scatter light, special imaging 
techniques may be needed for effective kinase activity visualization in vivo. Many 
studies use two-photon fluorescence imaging on surgically exposed tissues. 
Two-photon imaging, which uses two long-wavelength beams to excite only 
within a focal spot, offers better tissue penetration and reduced photobleaching 
compared to shorter wavelength illumination.  
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Expression level is a constant challenge in the development of biosensor-
expressing animals. Sensors can be silenced or recombined out of the genome 
(Yamaguchi et al., 2011), and they sometimes appear unpredictably in only a few 
tissues. For example, in a double-transgenic mouse line carrying two halves of a 
bimolecular reporter, both driven by the same ostensibly ubiquitous reporter, one 
was expressed reasonably brightly in a number of tissue types, whereas the 
second appeared only in testes (Audet et al., 2010). When expression is too low, 
effective FRET studies cannot be carried out because of extremely low signal-to-
noise ratios. Overexpression, however, may cause embryonic lethality or 
perturbation of the signaling system beyond physiological relevance (Hara et al., 
2004). Although transgenic calcium-sensing mice, including some that express 
FRET-based sensors such as Cameleon (Hara et al, 2004), have existed for 
some time, mice expressing kinase sensors have only recently became 
available. 
 A recent effort using cytoplasmic mRNA injection yielded mice 
ubiquitously expressing AKAR, EKAR and nucleus-targeted EKAR (Kamioka et 
al., 2012). These were used for several proof-of-principle studies, including 
comparative analysis of PKA and Erk responses to laser ablation of epidermal 
tissues. The authors propose that these mice may be useful for studying 
pharmacodynamics in vivo.  
The same mouse lines have also proven useful, albeit in a tissue-culture 
explant system, for studying relationships between signaling circuits. Gut 
explants from AKAR and EKAR mice were used to study the relationships 
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between pro-migration and anti-migration signaling circuits in organ-cultured 
enteric nervous system progenitor cells (Goto et al., 2013). By watching the 
relationship between location and kinase or GTPase activity in real time in a 
network of neural progenitor cells advancing along the gut, the authors 
determined that Rac1 and Cdc42 activity were highest toward the leading edge, 
both within and between cells, whereas PKA activity was lower in the migrating 
cells and higher in the stationary network cells.  The authors were also able to 
show that some kinases, such as JNK, that were purportedly required for 
migration, do not seem to affect its velocity or direction.  
Blending activity-based biosensing with two-photon techniques for chronic 
in-vivo neuron imaging, Mower et al. (2013) showed that CaMKII, mentioned 
above for its role in spine signaling in dissociated cultures, also plays a key role 
in spine and synapse maintenance in living brains. In ferrets expressing the 
CaMKII sensor Camui, delivered by viral vector, the authors determined that 
irrespective of starting spine size, dendritic spines with low basal CaMKII activity 
were more likely to be lost after sensory deprivation than spines with higher 
starting CaMKII.  
 
Case study: developing a sensor for I kappa B Kinase (IKK) 
 
Background 
 NFB is a family of immunomodulatory transcription factor, and one of the 
earliest demonstrated examples of signal-responsive modification of gene 
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transcription. In unstimulated cells, the transcription factor is found in dimer form 
in the cytoplasm, retained there by binding of one of a family of proteins known 
as the inhibitors of B. For our purposes, the most relevant is IB. Binding 
between NFB dimers and IB is thought to occlude the nuclear localization 
sequence of NFB (Beg et al., 1992). When phosphorylated by one of two IB 
kinases, IKK or IKK, IB is recognized and polyubiquitinated by a ubiquitin 
E3 ligase complex containing beta-TRCP, the beta transducin repeat containing 
protein (Traenckner et al., 1995; Suzuki et al., 2001). Polyubiquitination enables 
proteasomal degradation of IkBa (Chen et al., 1995). This frees NFB to 
translocate to the nucleus, where it binds DNA and facilitates the transcription of 
target genes (Roff et al., 1996). Among its transcriptional targets, are cytokines, 
membrane proteins, transcription factors and apoptosis inhibitors. NFB activity 
also targets IB and other suppressors of NFB activation, which mediate 
negative feedback to the NFB signaling circuit (Arenzana-Seisdedos et al., 
1995).  
 IKK activity is a necessary precursor to translocation and transcriptional 
activation of NFB, and can further control the dynamics of NFB signaling 
(Behar & Hoffmann, 2013). The two major IKKs, IKK and IKK, exist in a high-
molecular weight complex with one another and the regulatory subunit NEMO; 
however, they target different substrates, and are active in different cellular 
contexts. IKK is primarily a regulator of adaptive immune responses (for 
example, lymphocyte activation), whereas IKK governs innate immunity (Hacker 
& Karin, 2006). In the canonical pathway for IKK activation, IKK is activated in 
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response to cytokines such as TNFa or IL-1B, which are generally recognized by 
“death receptors” in the TNF receptor superfamily (see figure 3.3a). Two serines 
in the IKK activation loop can be phosphorylated by self-transphosphorylation or 
by a variety of upstream kinases, including NFB inducing kinase NIK, several 
MAPK kinases, and TGF activating kinase 1, in response to a variety of 
inflammatory signals (reviewed by Hosel & Schmid, 2013).  
Single-cell imaging, usually focused on IKK signaling induced by TNFa, 
indicates that NFB nuclear translocation is induced somewhat stochastically, 
with dramatic variation between individual cells exposed to the same stimulus. 
The percentage of mouse fibroblasts responding to a TNF stimulus increases 
with dose, but even at a high dose, not all cells respond (Tay et al., 2010). Given 
the complex system of feedback loops regulating this switchlike behavior, and 
the key role NFB plays in cellular decision-making, the pathway has evoked a 
great deal of interest from computational biologists. In a B cell receptor response 
pathway, it has been demonstrated that positive feedback at the IKK activity step 
may account for some of the switchlike nature of NFB signaling (Shinohara et 
al., 2014). There is also some computational evidence that persistent IKK activity 
can mediate longer term NFB signaling (Witt et al., 2009). A sensor to directly 
monitor IKK activity would be advantageous for use in this system in order to 
better characterize the signaling mechanisms controlling NFB activation, and to 





Strategies for IKK sensor design 
 The IB protein has many motifs conferring dynamic regulation. Most 
salient for a sensor is the IKK phosphorylation motif, including substrate serines 
32 and 36 and the region surrounding them (DiDonato et al., 1997). After IKK 
phosphorylation, the phosphorylated motif is recognized by an E3 ligase which 
polyubiquitinates lysines 21 and 22 (Scherer et al., 1995, Baldi et al 1996). The 
ankyrin repeat domain, located C-terminal to the kinase substrate domain, 
confers binding to p65 (Huxford et al., 1998). A sequence known as the PEST 
domain, C-terminal to the ankyrin repeats, is required for IB turnover, in 
collaboration with the proteasome (Mathes et al., 2008). This region can be 
phosphorylated by casein kinase II, an alternate route to stimulus-induced IB 
degradation (McElhinney et al., 1996; Kato et al., 2003). Another degron, 
described more recently, overlaps with ankyrin repeat 6 (Fortmann et al., 2015). 
The relative importance of ankyrin repeats and PEST for protein turnover in 
response to signaling has been debated for some time, but is outside of the 
scope of this work. 
Figure 3.4a shows a linearized schematic of full-length IB, along with 
the truncated sequences used in efforts by our group and others to optimize the 
IKK activity reporter (IKKAR).  In the unimolecular sensor and the initial 
bimolecular sensor, we included amino acids 22 to 41, in keeping with a previous 
sensor effort (Olson et al) (figure 3.4a-A). Then we expanded our strategy to 
include a PEST domain from the endogenous protein (3.4a-B). Another 
construct, which was tested only preliminarily and not reported in this work, 
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included both the PEST domain and ubiquitin/SUMO modified lysines 20 and 21 
(3.4a-C). Figure 3.4b shows a crystal structure of the ankyrin repeat domain of 
IB (teal) in complex with an NFB dimer of p65 and p50 (grays) (PDBe 1ikn, 
Huxford et al. Cell 1998).  
 In a 2008 study, Olson and colleagues generated a phospho-IkBa binding 
protein derived from fibronectin through mRNA affinity selection (Olson et al., 
2008). This approach uses a puromycin linkage to prevent disassociation of 
mRNA and protein, such that transcripts encoding protein products with the 
desired properties can be enriched and re-amplified, in a pseudo-evolutionary 
process. The fibronectin variant that was finally selected bound specifically to 
phosphorylated IB (amino acids 22-41), demonstrated by immunoprecipitation. 
When these two protein fragments were ligated into a CFP/YFP FRET sensor 
backbone, FRET was significantly higher when mixed with catalytically active IKK 
in vitro (see figure 3.3b). However, tests of the responsiveness of the novel 
sensor to stimulus-induced IKK activity in living cells were not reported, and 
personal communication by the lead author indicated that pilot studies had been 
unsuccessful (Olson et al., 2008). 
 In selecting a phosphorylated amino acid binding domain, in contrast with 
earlier efforts to sense IB phosphorylation, we opted to use the endogenous 
phosphorylated IB sensing protein, TRCP. TRCP forms the substrate 
recognition domain of a ubiquitin ligase complex that regulates degradation of 
IB, -catenin (Winston et al., 1999) and several cell cycle factors (Nakayama & 
Nakayama, 2005). Phosphorylated substrates are recognized by a repeating 
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motif known as the WD-40 domain, which positions nearby lysines for enzymatic 
transfer of ubiquitin (Wu et al., 2003). Tandem repeats of WD-40 assemble into a 
structure resembling a propeller, with substrate recognition at the center of the 
propeller (Wu et al., 2003; Evrard-Todeschi et al., 2008). The crystal structure of 
the 7xWD40 domain is shown in figure 3.4c, with a linear domain map below 
(figure 3.4d; PDBe 1p22, Wu et al., 2003). The section used for phospho-
recognition included amino acids 287 to 605, starting with a short sequence N-
terminal to the WD repeats and extending to the end of the endogenous protein. 
 Finally, we constructed a unimolecular sensor incorporating the WD 
phospho-recognition domain, using the same layout as the sensor developed by 
Olson et al. A schematic is shown in figure 3.4e. 
 
Selection of a sensor format 
In cells expressing the two sensors using the WDx7 domain for phospho- 
IB recognition, a unimolecular layout proved inferior to the bimolecular sensor. 
In Cos7 fibroblasts treated with the IKK-activating cocktail of 100 ng/mL TNF 
with the phosphatase inhibitor okadaic acid (500 nM), no FRET response was 
observable in cells expressing the unimolecular sensor, whereas a small subset 
of bimolecular-expressing sensor cells showed a small increase in FRET 
(representative curves shown in figure 3.5a). 
The unimolecular fibronectin-based sensor published by Olson et al. also 
proved inferior to the bimolecular WDx7-based sensor. In MEF cells, again 
treated with TNF (100 ng/mL) and okadaic acid (500 nM), the unimolecular 
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sensor curves remained at flatline, whereas most bimolecular sensor-expressing 
cells responded, indicating that the bimolecular layout was preferable for 
detecting responses (figure 3.5b). Baseline increases in FRET ratio of the 
bimolecular sensor, as observed before time 0 in figure 3.5b, were an issue 
limiting interpretation of the fold change. 
In line with the drifting FRET baselines, we observed significant 
phosphorylation of the IB portion of the bimolecular sensor even in untreated 
cells (figure 3.5c). High basal phosphorylation is likely to increase baseline FRET 
ratio and may limit the dynamic range of the sensor. We hypothesized that this 
high baseline phosphorylation derived from a lack of reversibility of sensor 
phosphorylation. Whereas many FRET sensors encode a kinase substrate 
domain that is also subject to reciprocal phosphatase activity, endogenous p- 
IB is not dephosphorylated, but it is subject to proteolysis. The NES-tagged 
IB truncation used lacks degradation motifs, which may have inhibited 
clearance of the phosphorylated protein. 
 
Optimizing a bimolecular sensor to minimize baseline phosphorylation 
 In order to provide an avenue for degradation of phosphorylated sensor 
protein, we introduced a PEST sequence from endogenous IB, replacing the 
nuclear exclusion sequence in the initial bimolecular layout (see figure 3.4a-B). 
With this modification, the fold increase in phospho- IB was much more 
dramatic (figure 3.6a, p- IB strip, lanes 7-8 vs. 9-10). YFP expression was also 
reduced (figure 3.6a, YFP strip, lanes 1 vs. 3, 7 vs. 9). 
79 
 
 Rapid degradation of phosphorylated sensor components, while useful for 
reducing the FRET at baseline, could also hinder FRET-based visualization of 
phosphorylation in real time. Therefore, we treated cells expressing the PEST-
tagged sensor with the proteasome inhibitor MG132 at 20 uM for one hour prior 
to imaging (figure 3.6b). Pretreatment rescued average YFP intensity at the start 
of imaging from 1400 AFU in untreated cells to 6800 AFU treated cells in 3.6b; it 
also appeared to potentiate greater FRET responses to TNF alpha (figure 3.6b). 
 In keeping with the dramatically lower phospho- IB signal observed by 
Western blot in the degradable sensor compared to the NES-tagged sensor, we 
observed a significantly greater average FRET response in direct comparisons 
between PEST- and NES-tagged IKKAR variants exposed to the same TNF 
stimulus and MG132 pretreatment (figure 3.6c). 
 Even with a more responsive sensor, apparent TNF response was 
somewhat stochastic. Exposure to the strong IKK stimulant of bacterial 
lipopolysaccharide following TNF treatment led to a plausible FRET response in 
about one in every five cells (figure 3.6d-e). It remained to be validated whether 
these cells with apparent IKK activity also displayed NFB nuclear translocation 
in response to inflammatory stimuli. 
 
Limitations to IKK sensor use 
In preparation to test coimaging of p65 and the IKK sensor, we 
coexpressed each sensor component with RFP-tagged p65, an NFB monomer. 
Coimaging indicated that expression of the two sensor components together was 
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associated with significantly higher basal p65 nuclear/cytoplasmic ratio than p65 
expressed alone or with either sensor component in isolation (figure 3.7a). This 
was a concerning reminder that expressing signaling components can perturb 
the system. Similarly, in a small sample set imaging the nuclear to cytoplasmic 
ratio of p65 in cells expressing or failing to express IKKAR within the same dish, 
it was apparent that the presence of sensor components altered signaling 
dynamics (figure 3.7b). 
To minimize baseline IKK signaling and optimize the number of cells 
responding, we tested a period of serum deprivation prior to TNF treatment, 
borrowing from the classic NFB literature (e.g., Ozes et al., 1999). However, a 
more recent publication suggests that IKK may be activated by serum starvation 
(Kohno et al., 2012). Moreover, we observed that serum starvation dramatically 
affected localization of the WDx7 sensor domain (figure 3.7c). With increasing 
serum deprivation of Cos7 cells, perinuclear puncta appeared in the CFP 
channel, which we hypothesized could represent either autophagic body 
formation, or unfolded and aggregated CFP-WD proteins. Successful in vitro 
translation of catalytically active full-length TRCP in a rabbit reticulocyte lysate 
model system, and purification and crystallization of the WD repeat domain 
alone, had suggested folding of this domain was robust (Wu et al., 2003; Evrard-
Todeschi et al., 2008). In any case, efforts to find a less stressful pre-imaging 






Although credible FRET responses to IKK stimulation were occasionally 
observed in our experiments, the drawbacks of the bimolecular IKK sensor 
remain significant. Problems encountered in the course of this research included 
high basal phosphorylation of the substrate component; poor cellular distribution 
of the phospho-substrate binding component; and apparent interference of 
sensor components with endogenous signaling. 
Incorporating a degradation motif and then halting its degradation 
immediately prior to imaging appears to have solved the problem of high basal 
IB phosphorylation. Further experimentation might inform as to whether the 
same goal can be accomplished with the smaller, ubiquitin-only modification to 
the protein shown in figure 3.3a-C. Alternatively, recent work has shown that a 
domain distinct from the PEST may be important in IB degradation (Fortmann 
et al., 2016), indicating that greater turnover of the phosphorylated IB-YFP 
component might be possible. On the other hand, WDx7 domain folding and/or 
localization failed intermittently, apparently as a result of cell stress, and we were 
not able to resolve the problem satisfactorily. In particular, serum starvation to 
reduce NFB activation at the outset of imaging seems to have worked against 
our goal on this front.  
To optimize these problems intrinsic to the sensor, a more promising path 
forward may be to combine the optimized kinase substrate domain with a more 
easily-folded phospho-recognition domain: for example, using the PEST- tagged 
IkBa component with the fibronectin-based selex product in a bimolecular sensor 
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format. This combination may optimize both the fold change in phosphorylated 
IKK substrate from untreated to treated cells, and the ease of folding of the 
phospho-recognition component of the sensor. 
Any future efforts to generate an IKK activity sensor, however, must 
remain mindful of the possible perturbation to activity of the signaling pathway 
when introducing excess substrate and binding domains. As shown in figure 
3.7a-b, expression our intermolecular sensor introduced significant perturbation 
to NFB level and stimulus response. It is reasonable to suppose that the 
components of the bimolecular sensor could bind to, and interfere with, the 
endogenous molecular signaling system. An observation-induced “buffering 
effect” on endogenous signaling has been described and kinetically modeled for 
GTPase activity sensors, and there is evidence that our model system may also 
suffer from interference by observation (Haugh et al., 2012). Perhaps an avenue 
for circumventing this problem would be to engineer an intramolecular sensor 
optimized for low binding to endogenous protein, along an approach comparable 










Figure 3.1 The pipeline for biosensor development. (A) Design. The majority 
of two fluorescent protein reporter layouts position the fluorescent protein pair 
around a molecular switch, either endogenous or engineered. (B) Development is 
typically an iterative process. (C) Initial characterization of a reporter involves 
measuring its response to a known stimulus of the kinase of interest; here, “a” 
represents an earlier version of a sensor with lower dynamic range, whereas “b” 
represents activity of an optimized version. (D) Optimization of a reporter may 
involve changing the fluorescent proteins, linker, or length/identity of the specific 
protein components recognizing the signal of interest. After optimization, new 
versions of a probe are compared to earlier versions. (E) Application of a probe 
in cell lines, primary cells and live animals can be both an end goal for 
development, and a spur to further optimization. 
B.#Development*








Figure 3.2 Visualizing a protein’s conformational change using an 
engineered polypeptide sequence. (A) Sensing unit: a molecular switch, 
usually based on the endogenous sequence of a kinase or its substrate. On/off 
“switching” may occur endogenously, as in a conformational change or a binding 
event; or be engineered, as in a unimolecular adaptation of a binding event, or a 
pseudoligand displacememnt probe. (B) The reporting unit generates an optical 
readout, either through a change in single-color fluorescence, or by a change in 
resonance energy transfer. Dimerization-dependent fluorescent protein intensity 
















Figure 3.3. Pathways for IKK activation. (A) Canonical pathway for NFB 
activation. (B) Conceptual schematic (left) and spectroscopic curves (right) of 
fibronectin-based IKK sensor. Reprinted with permission from Olson et al., ACS 






Figure 3.4. Endogenous components of an IKK sensor. (A) Domain map of 
IB and YFP-tagged truncations. (B) Crystal structure of IB (amino acids 70-
282) in complex with NFB heterodimer (gray) (PDB 1ikn). (C) Crystal structure 
of the beta-propeller sheet structure of TRCP (orange) in complex with a 
phosphorylated fragment of beta-catenin (not shown) (PDB 1p22). (D) Domain 
map of TRCP and CFP tagged truncation. (E) Domain map of a unimolecular 






Figure 3.5. First steps toward a bimolecular IKK sensor. (A) Unimolecular 
sensor using IB -NES and TRCP is inferior to bimolecular sensor using same 
components. Cos7 cells, treated with TNF (100ng/mL) and okadaic acid (500 
nM). (B) Unimolecular sensor using IB and SELEX-derived, fibronectin-based 
phospho- IB binding domain is inferior to bimolecular sensor using IB -NES 
and TRCP. MEF cells, tnf 100 ng/mL, KOA 500 nM. (C) IB -NES is highly 





Figure 3.6. Incorporation of degradation domains.  (A) Incorporation of a 
PEST motif reduces basal IB phosphorylation, driving a stronger fold increase 
in phosphorylation after TNF treatment. (B) Cos7 cells expressing bim-IKKAR 
with a PEST domain show greater FRET response to 25 ng/mL TNF when 
pretreated with MG132 (navy traces) than without pretreatment (purple traces). 
(C) Cos7 cells expressing bimolecular IKKAR with a PEST domain (maroon) 
show, on average, a stronger FRET response to TNF than cells expressing 
bimolecular IKKAR with a nuclear exclusion sequence (NES, black). All cells 
pretreated with 20 uM MG132. (D-E) In separate experimental replicates, HeLa 
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cells tended to show a relatively modest response to TNF which could be 
potentiated by followup treatment with lipopolysaccharide (LPS). 
 
Figure 3.7. Limitations to IKKAR imaging. (A) Expression of paired IKKAR 
components correlates with high baseline nuclear p65 localization (* ANOVA, 
p<0.05). (B) Both starting nuclear/cytoplasmic ratio and signal-induced nuclear 
translocation of p65 are substantially altered in cells expressing both IKKAR 
components (blue traces), compared to cells expressing p65 alone in the same 
dish (red traces). (C) Serum starvation appears to drive formation of CFP-WDx7 




Table 3.1 List of genetically encoded kinase biosensors for kinase 
activation (measured by conformational change) or activity (measured by 
substrate phosphorylation). 
 
Target Sensor name References 
Activation probes   
Akt AktAR Gao et al., 2008, 
Komatsu et al. 2011 
 GFP-PKB-RFP Calleja et al, 2007 
 ReAktion Ananthanarayan et al, 
2007 
B-Raf Prin-BRaf Terai & Matsuda, 2006 
C-Raf Prin-CRaf Terai & Matsuda, 2005 
Death associated protein kinase 1 
(DAPK1) 
 Piljic et al., 2011 
CamKII Camui Takao et al., 2005, 
Piljic et al., 2007, 
Kwok et al., 2008 
Erk Miu2 Fujioka et al., 2006 
P21-activated kinase 1 (PAK1) Pakabi Parrini et al., 2009 
Activity probes   
Protein kinase A AKAR Zhang et al., 2001… 
Komatsu et al., 2011 
Abl kinase  Zhou et al., 2009 
Akt Aktus Sasaki et al., 2003 
 Akind Yoshizaki et al, 2007 
 BKAR Kunkel et al, 2005 
AMPK AMPKAR Tsou et al., 2011 
Aurora B kinase Aurora B 
sensor 
Chu et al., 2011 
ATM kinase Atomic Johnson et al, 2007 
Protein kinase C CKAR Violin et al., 2003, 
Komatsu et al., 2011, 
Wu-Zhang et al., 2012 
Cyclin-dependent kinase 1   Gavet & Pines, 2010 
Cyclin-dependent kinase 2  Spencer et al., 2013 
Protein kinase D DKAR Fuchs et al., 2009, 
Eisler et al., 2012 
EGFR  Ting et al, 2001, 
Erk Erkus Sato et al, 2007 
 EKAR Harvey et al. 2008, 
Komatsu et al., 2011 
 REV Xu et al., 2013 
Focal adhesion kinase (FAK)  Seong et al., 2011 
Inhibitor of kappa B kinase (IKK)  Olson et al., 2008 
Insulin receptor Phocus Sato et al., 2004 
 Sinphos Kawai et al., 2004 
c-Jun N-terminal kinase (JNK) JNKAR Fosbrink et al., 2010, 
Komatsu et al., 2011 
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MAPK- activated protein  
kinase 2 (MK2)  
GMB Neininger et al., 2001 
Microtubule affinity regulating kinase 
(MARK) 
Timm et al., 2010 
Myosin light-chain kinase (MLCK) exMLCK Geguchadze et al., 
2004 
   
Phosphoinositide-dependent 
kinase 1 (PDK1) 
GFP-PDK1-
RFP 
Calleja et al., 2007 
 
Polo-like kinase 1 Plk sensor Macurek et al., 2008 
RSK Eevee-RSK Komatsu et al., 2011 
S6K Eevee-S6K Komatsu et al., 2011 




Tomida et al., 2009 
Src Src biosensor Ting et al, 2001,, 
Wang et al, 2005, 






Chapter 4. Conclusions and perspectives 
 
Outlook for lin28a/TRBP interaction 
 
 We have characterized an interaction between Lin28a and TRBP that 
depends on Erk-induced phosphorylation of TRBP and also Lin28a 
phosphorylation. There is considerable precedent for the mediation of other 
TRBP binding partners through kinase activity: for example, in TRBP binding to 
Dicer, PACT and PKR (see chapter 1). The effect of Lin28a phosphorylation on 
its interactions is comparatively unexplored. 
Preliminary phosphomutant experiments (figure 2.3H-I) suggest that the 
biosensor is in fact a dual sensor, with maximal interaction between Lin28a and 
TRBP mediated by phosphorylation of both proteins. It is counterintuitive to 
imagine that addition of a highly electronegative phosphate group to each of two 
small binding partners increases their attraction to one another. However, 
perhaps phosphorylation drives a significant conformational change in one or 
both sensor components, revealing a binding domain that is otherwise occluded.  
Dual phosphorylation adds a layer of complexity to any molecular model of the 
Lin28a/TRBP sensor: instead of a switch with two states, as described in the 
section of chapter 3 on designing a probe, the sensor now represents a switch 
with numerous possible conformations. That is, phosphorylation status of both 
Lin28a at serine 200, and TRBP at serine 152 may contribute to overall strength 
of binding. Experiments to test FRET efficiency in Lin28a phosphomutant and 
phosphomimic constructs are ongoing, and their results are anticipated with 
eager interest. One kinetic correlate of a sensor reporting two phosphorylation 
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events, is that if the two phosphorylation reactions proceed at different rates, a 
slower FRET increase might be expected compared to a single phosphorylation 
sensor. In effect, the sensor would report on a second-order rather than a first-
order reaction. Indeed, we observed slow binding kinetics in the Lin28a/TRBP 
sensor compared to an Erk sensor. We wonder which is the rate-limiting Erk 
substrate, and whether factors beyond kinase activation and localization may 
affect phosphorylation rates. For example, does the RNA binding status of lin28a 
C terminus affect its availability to be phosphorylated?  
 From a more biological standpoint, we wonder about the relative 
importance of phosphorylation of each protein in the observed physiological 
output of heightened Lin28a levels downstream of Erk activity. Is there a 
meaningful difference between instances when lin28a alone is phosphorylated 
and stabilized, and those when TRBP phosphorylation coincides with lin28a 
stabilization? The modest increase in Lin28a level consistently observed in TRBP 
deficient cells after Erk activation with PMA (figure 2.2) suggests that Lin28a can 
respond to Erk stimulation in the absence of TRBP. In contexts where TRBP is 
not overexpressed, but present at endogenous levels, what is its quantitative 
impact on Lin28a level?  
 Another interesting question is whether the interaction between Lin28a 
and TRBP, and the increase in Lin28a protein levels it potentiates, primarily 
exerts downstream effects through upregulation of microRNA biogenesis, or 
through other modes of Lin28a activity. Endoplasmic reticulum associated 
translation is one system in which Lin28a and TRBP exert similar influences, and 
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may interact. TRBP phosphorylation in the peri-endoplasmic reticulum is known 
to increase JNK and PKR activity, reducing translation; while TRBP also 
potentiates microRNA biogenesis in the rough endoplasmic reiticulum  
(Nakamura et al., 2015; Stalder et al. 2013). Meanwhile, Lin28a has been shown 
to suppress translation through mRNA binding in the endoplasmic reticulum in 
the secretory pathway within embryonic stem cells (Cho et al., 2012) If 
heightened interaction between Lin28a and TRBP were observed in the peri-
endoplasmic reticulum, it might suggest an interesting role for spatial control of 
this interaction in known functions of each protein. 
 A limitation of all of the experiments discussed in this dissertation is that 
they used overexpressed, affinity-tagged constructs, and therefore cannot be 
directly compared with endogenous cellular signaling systems. It is possible, 
although unlikely, that we may have measured ectopic interaction of two proteins 
that never in fact interact in a cellular context—for example, if they are confined 
in different cytoplasmic compartments. Moreover, the bimolecular protein/protein 
interaction sensor approach has limitations and drawbacks. For example, we 
could not observe Lin28a/TRBP interaction in a neuronal context; however, 
failure of the two halves of the probe to colocalize evenly throughout neurons 
makes this result inconclusive. 
 Further development of the Lin28a/TRBP biosensor might focus on the 
tradeoffs of intramolecular versus bimolecular sensor formats. In general, 
bimolecular sensors have higher dynamic range than their unimolecular 
counterparts (Depry et al., 2015). It is not yet clear whether the benefit a 
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unimolecular sensor offers for in vivo characterization of Lin28a/TRBP 
interaction, by forcing colocalization of both components, will outweigh the 
probable loss of dynamic range apparent from an increase in basal FRET 
efficiency (figure 2.6e). In either case, it is essential to ascertain that the final 
product is used in biologically meaningful settings by validating the expression of 




Outlook for IKK sensing 
 
 Limited work on the problem of an IKK sensor suggests that the designer 
of a biosensor must be flexible in selecting from naturally-derived and engineered 
sensor components. The synthetic unimolecular probe developed by Olson et al., 
which restricts endogenous sequence to the IKK substrate, displays high basal 
FRET when expressed in cells; this problem had to be solved by introducing 
endogenous IB turnover mechanisms. On the other hand, the endogenously-
derived phosphopeptide binding domain investigated in this work was not reliably 
expressed. As described in chapter 3, a reasonable compromise might be to 
combine the optimized IB peptides with the better-expressing phospho- IB 
binding protein derived from fibronectin. Future tinkerers with an IKK probe might 
benefit from trying such a combination.  
 That said, the need for a reversible mechanism of clearance for basal 
probe activity, such as the MG132-reducible turnover of the phosphorylated IKK 
substrate, introduces an additional perturbation of the system with treatment. 
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Another limitation to this study is the disruption of NFB signaling that we 
observed (figure 3.8). Historically, observer-induced disruption to NFB signaling 
has been ameliorated using knock-in NFB-FP constructs rather than 
overexpressed transfected constructs. Preliminary data suggest that knock-in 
approaches may be feasible for biosensor imaging, and we anticipate interesting 
work in this arena. 
 Another option is to forego measurement of IKK substrate phosphorylation 
and focus instead on the phosphorylation status of the IKK activation loop. This 
approach would provide a readout of kinase activation, rather than kinase 
activity—a subtly distinct measurement (see chapter 3). Such reporters exist for 
a number of enzymes (see table 3.1), some of whose activity has not also been 
captured in activity reporter form.  
 Development of a functional sensor for IKK activity is far from complete, 
and experience indicates that the way forward may not be direct. However, the 
questions that such a sensor could address are numerous and interesting. For 
example, mathematical models indicate that different profiles of IKK activation 
may mediate changes in the dynamics of various IB/NFB pairs, allowing for 
varied responses to inflammatory stimulants (Alves et al., 2014). A sensor would 
help to test model-based predictions about the signaling that drives these IKK 
activity profiles. 
 
Outlook for FRET biosensors of kinase activity 
As a review of studies into well-studied kinases such as PKA, CaMKII and 
Erk makes clear, kinase activity reporters can be an extraordinarily useful tool for 
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understanding the target enzyme and its adaptors, modulators and cofactors. As 
new probes are developed, and existing probes optimized for primary culture and 
in-vivo imaging, we anticipate similarly diverse findings in many pathways. 
Progress is underway at many points in the biosensor development pipeline, 
from target selection through optimization to live-animal applications. 
Our experience underlines the dual uses of a novel biosensor. In the 
absence of a well-characterized, structurally defined interaction between Lin28a 
and TRBP, it was initially possible to misinterpret FRET changes in the 
Lin28a/TRBP sensor as driven exclusively by TRBP phosphorylation, which had 
been previously described, and focus biosensor development on imaging in 
physiological contexts. Subsequent data suggest that phosphorylation of both 
sensor components is necessary, complicating our understanding of this 
interaction (figure 2.3H-I). The availability of the biosensor offers the potential to 
rapidly assay mutant constructs to test new hypotheses regarding post-
translational modifications to Lin28a.  
Work in this thesis highlights the challenges of minimizing perturbations 
while maximizing signal-to-noise ratio in visual readouts of cellular signaling 
systems. Surprisingly few publications have formally addressed this problem. 
However, our observation of IKKAR-associated perturbation of baseline NFB 
localization suggests that overexpressing small functional domains of signaling 
proteins may be sufficient to change the dynamics of the whole system. A study 
concerned with biosensors that bind to third-party analytes found that, in a 
computational model, expressing an excess of biosensor would significantly alter 
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the accumulation and diffusion of the analytical target, while expressing too little 
biosensor would saturate the fluorescence readout (Haugh, 2012).  While the 
buffering effect of a sensor made to be enzymatically modified itself, rather than 
binding an external molecule, may be less dramatic, based on the perturbations 
to NFB ratio we observed, the disruptive principle evidently remains relevant. 
 Another theme in this work is the difference in signal using bimolecular 
compared to intramolecular sensors, even if these sensors are otherwise 
identical. In general, intramolecular sensors display greater baseline FRET, both 
because tethering increases the effective concentration of the binding 
components, and because the fluorophores start in closer proximity even without 
basal binding. However, intramolecular sensors may also potentiate faster FRET 
kinetics and reduced off-target binding to cell system components. Therefore, as 
noted in chapter 3, the best format for a sensor may depend on the use case. 
For the purposes of optimization, structural studies of extant probes will be 
important to advance our understanding of sensor technology and settle open 
questions about how probes function. For example, a small-angle X-ray 
scattering (SAXS) study with the calcium sensor TN-XXL showed that distance 
played a greater role than orientation in the FRET efficiency of the calcium-free 
form of the sensor (Geiger et al., 2012). Further insight into what specific 
conformational changes lead to the greatest FRET change will be beneficial for 
future probe design; another recent study used SAXS assessment of the 
distance between fluorescent proteins in a probe’s off-state and on-state to 
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predict the maximal expected FRET change (Mertens et al., 2012). Such 
information will enable rational design and modification of future probes. 
Some genetically encoded biosensors have been used in high-throughput 
compound screens (reviewed by Robinson et al., 2014).  Further enhancement of 
the dynamic range could facilitate this application in cellular contexts to 
complement FRET-based inhibitor screens using synthetic sensors outside of the 
cellular context (e.g., Gratz et al., 2011). Another application of genetically 
encoded sensors where we expect to see further advancement is kinase inhibitor 
candidate validation (e.g., Timm et al., 2011), including validation of inhibitors’ 
isoform specificity (Tsalkova et al., 2012), and analysis of pharmacokinetics in in 
vitro or in vivo models (Nobis et al., 2013). 
In vivo imaging of FRET biosensors within living animals is now a practical 
proposition (Day et al., 2016). The reduction in signal-to-noise ratio and dynamic 
range observed in many in vivo systems necessitates probe optimization and 
modification, for example, red-shifting of sensors (Lohse et al., 2012). It is 
important to keep in mind that improvements in one parameter may come at the 
cost of others, and that different versions of a sensor may be best suited to 
different applications. We look to the explosion of live animal studies with 
genetically encoded calcium indicators (reviewed by Palmer et al., 2011; Tian et 
al. 2012) as a model for the way forward with kinase sensors. In particular, 
iterative optimization has proven successful for genetically encoded calcium 
indicators, where often an early version shows very weak response in live 
animals, but subsequent versions are more effective. Advances in in vivo 
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imaging technology, used in combination with improved probes, will further 
expand the reach of kinase and phosphatase sensors. In vivo imaging that can 
be carried out over developmental time-courses, using lower illumination; in 
intact tissues, using higher-penetrance illumination techniques; and in freely 
behaving animals, using flexible optical devices, will be key to our understanding 
of signaling in the context of systems that are difficult to model in vitro.  
 In conclusion, fluorescence-based biosensors have come a long way, and 
continue to shine a light on cellular activity. We anticipate a fruitful future for 
these tools in expanded applications, yielding many more lessons about the 




Appendix 1: extended experimental methods 
 
Restriction Cloning 
 TRBP truncations (as published (Daher et al., 2001) were N-terminally 
tagged with myc (MEEQKLISEEDL), or fluorescent proteins Cerulean (Rizzo et 
al., 2004), Cerulean-3 (Markwadt et al., 2011), or ECFP (Llopis et al., 1998). 
Lin28a truncations were derived from FL-Lin28a (Amen et al., 2017) by PCR and 
tagged with flag (DLYDDDKD) at the N terminus or YFP variants Venus (Nagai et 
al 2002), Citrine (Griesbeck et al., 2001), cpVenus-E172 and cpVenus-L194 
(Nagai et al 2004) at the C terminus. EKAR ratiometric Erk sensor was a gift from 
R. Campbell (Addgene plasmid #60974). 
PCR primers were designed using SerialCloner or Snapgene and checked 
for secondary structure, self-dimerization and heterodimerization using the 
OligoAnalyzer web tool provided by IDT. When restriction sites were added 
through PCR, PCR protocol was designed so that the first cycle matched the 
initial primer/template annealing temperature, and subsequent cycles matched 
the full-primer melting temperature. For example, a protocol frequently used to 








98  * 0:10 
64 0:30 
72 0:45 




When subjecting PCR products to restriction digest, 40 uL kit-purified PCR 
product was digested with at least 2 uL FastDigest restriction enzyme in 1x 
Cutsmart buffer for 1-3 hours at 37C. Plasmid vectors were digested (1 ug) using 
1 uL of each of two FastDigest restriction enzymes in 1x CutSmart buffer with at 
least 30 uL reaction volume. After 1 hour digestion, shrimp alkaline phosphatase 
(SAP, 1 uL) was added. Restriction fragments were resolved in a 1% agarose gel 
in SB buffer. Agarose was melted and fragments were recovered using a gel 
purification kit.  
Plasmid/insert ligations were prepared using T4 DNA ligase in a 10 uL 
reaction volume. DNA needed for the specified molar ratio of vector:insert 
(usually 1:3; 1:1 and 1:10 were used to optimize recalcitrant reactions) was 
calculated using a web tool provided by the University of Dusseldorf Molecular 
Biophotonics Group. http://www.insilico.uni-duesseldorf.de/Lig_Input.html. Where 
possible, 50 ng vector was used. If combining adequate vector, insert and buffer 
exceeded 10 uL reaction volume, less vector was used. After 15 minutes-1 hour 
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ligation at room temperature, or overnight ligation at 16C, 5 uL ligation product 
was transformed into homemade transformation-competent bacteria (see below). 
 
Site-Directed Mutagenesis 
Phosphomimic and phosphomutant versions of all TRBP and Lin28a 
constructs were derived from wild-type versions of these constructs, using a 
modified version of the protocol presented by Huang and Zhang (2016). 
 Protocol: first, 100 uM primer was phosphorylated in the following mixture 
at 37C for 30 minutes to 1 hour.   
Reagent volume 
100 uM primer 5 uL 
10x T4 PNK buffer 5 uL 
10 mM ATP 5 uL 
ddH20 34 uL 
T4 polynucleotide kinase (PNK) 1 uL 
Total 50 uL 
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Phosphorylated primer  
(from step 1) 
1 uL 
DNA template  0.2 ug in 1 uL 
10x Pfu Buffer 1 uL 
10x Taq Ligase Buffer 1 uL 
2.5 mM dNTPs 1.5 uL 
Pfu DNA polymerase 0.5 uL 
Taq ligase 0.5 uL 
ddH2O To 20 uL 
 
Mutant template was created by PCR using the protocol “QuickA.”  
Temperature Time (m) 
65 5:00 
96 0:30 








Remaining methylated template was digested for 1 hour at 37C using 1 uL Fast 
Digest (FD) Dpn1. Then the tube was returned to the thermocycler for PCR 
protocol “QB”: 
  
Temperature Time (m) 
65 5:00 
96 0:30 
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 Aliquots of bacteria competent for transformation (stored at -80C) were 
thawed on ice, and up to 5 uL ligation product or plasmid prep was added to 
aliquot under flame-sterile conditions. After 15 to 30 minutes on ice, this mixture 
was heat shocked at 42 C for 45 seconds, then returned to ice for a two to three 
minute recovery period; warmed LB+ was added under flame-sterile conditions, 
and cultures were rotated for 30 minutes to an hour at 37C before plating onto 





HEK 293T cells were cultured in DMEM supplemented with 10% FBS and 
peneillin/streptomycin, and transfected as described (Amen et al., 2017). For 
stabilization experiments, 45,000 cells per well were seeded onto 24-well culture 
plates, and transfected using the calcium phosphate protocol 18 to 24 hours after 
plating. Media was changed 8 to 16 hours after transfection, and cells were 
harvested 36 hours after transfection (for experiments testing only coexpression) 
or up to 48 hours after transfection (for experiments requiring, e.g., 24 h  
treatment).  When multiple truncations of the same protein were expressed for 
the same experiment, transfection levels were optimized to equalize affinity tag 
level in lysates from different truncations. Total DNA transfected was equalized 
between conditions using empty pcDNA vector.  
Mouse tail epithelial fibroblast cells (TEFs) lacking endogenous murine 
TRBP (Tarbp2 KO) (gift of A.Gatignol, (Daher et al., 2009)) were cultured in 
DMEM with 10% FBS supplemented with penicillin, streptomycin and 
amphotericin B. Cells were seeded at 15,000 cells per well in 24-well plates, 
followed by lipofectamine LTX Plus transfection according to manufacturer 
protocol.  
For neuronal imaging experiments, murine hippocampal neurons were 
cultured as described (Amen et al., 2017). Briefly, hippocampi were isolated from 
neonatal ICR mice, then neurons were dissociated using papain and physical 
dissociation, and plated at 180,000-200,000 cells per dish in polylysine-coated 
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MatTek imaging dishes. Neurons were cultured in Neurobasal A medium 
supplemented with B27 and glutamine, with penicillin/streptomycin for the first 24 
hours. After 13-14 days in vitro, neurons were transfected using lipofectamine 




Cultured cells were washed in cold PBS and harvested on ice with lysis buffer 
(50 mM HEPES, 150 mM NaCl, 10%Glycerol, 1 mM EDTA, 1% Triton X-100, 
0.2% SDS) plus protease inhibitor cocktail (Roche 11836170001), and 
phosphataseinhibitors (sodium orthovanadate 0.2 mM, sodium pyrophosphate 1 
mM). Protein concentration was determined by Bicinchoninic acid (BCA) assay 
and equal protein amounts resolved on SDS-PAGE gels and electrotransferred 
to PVDF membrane. Membrane was blocked with 5% BSA in Tris-buffered saline 
tween 20 (TBST 0.1%) for 1-3 hr and probed with primary antibodies: c-Myc 
(Lifetech 132500), FLAG (Sigma M2, F3165) TRBP (Abcam ab72110,or 
Proteintech 15753-1-AP), Phospho-TRBP (custom), Hsc70 (Santa Cruz sc7298). 
All immunoblots were scanned and quantified without image adjustment. For 
representative image figures, image levels were uniformly and minimally adjusted 
for visual clarity in some instances. 
 
Immunoprecipitation from cells 
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For FL-Lin28a co-immunoprecipitation of TRBP and its truncations, mouse 
anti-flag M2 antibody (Sigma) was adhered to protein G sepharose beads 
overnight after blocking with 5% BSA for 1 hour. HEK 293T cells coexpressing 
the constructs of interest were harvested in coIP lysis buffer (100 mM KCl, 4 mM 
MgCl2, 10 mM HEPES (pH 7.3), 50 uM ZnCl2, 0.5% NP-40) with protease 
inhibitor cocktail (Roche), and phosphatase inhibitors (Sigma, phosphatase 
inhibitor cocktail 2 and 3).  Insoluble material was first removed by centrifugation 
(10,000 g) and lysates pre-cleared by rotation (4 °C, 1 hr) with unblocked 
sepharose beads. Equal masses of protein in pre-cleared lysates were brought to 
equal volume, added to flag antibody-coated beads, and rotated (4 °C, 3-4 hr).  
After washing 3x with coIP wash buffer (150 mM NaCl, 1 mM MgCl2, 50 mM 
HEPES (pH 7.8), 50 uM ZnCl2, 0.05% NP-40), immunoprecipitated material was 
eluted at room temperature using 1x flag peptide (Sigma F3290) diluted 1:30 in 
coIP wash buffer. Protocol is reproduced below. 
 
Protocol for immunoprecipitation 
Day Prior to Immunoprecipitation 
1. Aliquot 30 uL 50% sepharose bead slurry per IP reaction 
2. Block beads for 1 hour, rotating at 4C, in coIP buffer + 5% BSA 
3. Pellet beads (spin 200rpm for 25 sec at 4C, suction off supernatant with 
thin-gauge needle or a p10 tip). Rinse with 1.5 mL chilled coIP buffer. 




Day of Immunoprecipitation 
Prepare beads 
1.      Aliquot beads for pre-clearing (20 uL 50% slurry per reaction) 
2.      Wash antibody-coated beads from day 1 and preclearing beads 
twice with 1.5 mL chilled NT2 (invert, spin 2000 rpm for 25 sec 4C, suction 
off buffer with needle & repeat) 
3.      Resuspend beads in 2x excess of NT2 + protease/phosphatase 
inhibitor + NEM (30 uL per 15 uL beads) 
Lyse cells 
1.      Wash cells with ice-cold PBS + 0.9 mM MgCl2 (be very gentle; if 
cells lift off, pellet them and add back to lysis buffer later.) 
2.      Harvest cells in polysomal lysis buffer + protease inhibitors, 
phosphatase inhibitor, 1 mM DTT. 
1.      For 24-well plates, use 50 uL per well (70 uL for first well) 
2.      For 10-cm dishes, use 750 uL per dish 
3.      Let cells sit in lysis buffer on ice 10 min, scrape and rotate at 4 C 10 
minutes 
4.      Centrifuge lysate at 13.2k rpm, 4 C for 15 minutes. Remove 
supernatant. 
5.      Begin pre-clearing on supernatant (less 1 uL for Bradford assay-see 
step 6). Pre-clear with 15 uL beads (=45 uL 33% suspension). Incubate, 
rotating, at 4C for as long as Bradford and calculations take. 
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6.      Bradford assay to determine concentration. 1 uL lysate : 200 uL 
Bradford reagent, invert 2-3x and incubate RT 10 minutes. 
Immunoprecipitate 
1.      Calculate volume for 1.5 mg protein per reaction; bring all samples 
to equal volume/concentration with extra lysis buffer (smaller volume = 
better IP!). 
2.      Spin cleared lysate 2000 rpm for 1 minute at 4 C and remove 
cleared lysate to a new tube. 
3.      Take two 2.5% input sample (2.5% of volume transferred, divided by 
3 for 3x elution). 
4.      Add 45 uL antibody-bound beads (15 uL in 33% suspension) to 
appropriate volume of cleared lysate. 
5.      Incubate, rotating, 3½  hours at 4 C.  
Wash 
1.      Spin down, take cleared lysate sample (2.5 % of (volume transferred 
+ 30 uL), divided by 3 for 3x elution) 
2.      Wash 2x with 1.5 mL ice cold NT2 + protease and phosphatase 
inhibitors; after each wash, invert to resuspend, spin beads at 2000 rpm 4 
C for 25 s. 
3.      Wash a third time with 1.5 mL ice cold NT2 + protease and 
phosphatase inhibitors – this time rotate at 4C 10 minutes before 
removing supernatant. (NB: if adherence is low, skip this step). 
111 
 
4.      Wash 1x with cold NT2 without protease/phosphatase inhibitors; 
spin for 1 minute at 2000rpm at 4 C, and remove buffer entirely with 
vacuum suction. (err on the side of leaving buffer rather than suctioning up 
beads; may remove last 30uL or so with pipettor instead!) 
Elute with Flag peptide 
1.      Add 30 uL of 1:30 dilution of Flag peptide in NT2; rotate 30 min at 
room temp 
2.      Spin 10 sec, 12000 rpm at room temp. Collect 30 uL eluent. 
3.      Repeat 2x (total 90 uL eluent) 
4.      Combine eluents and spin for 10 sec at 2000 rpm 
5.      Pipet off 30 uL eluent 
6.      Boil samples with loading dye for SDS-PAGE analysis. 
 
In vitro immunoprecipitation of recombinant proteins 
For in vitro characterization of binding between TRBP and lin28a 
truncations, full-length GST-TRBPdD or GST peptide only were harvested from 
BL21 E. coli (see protocol below) and purified over glutathione sepharose resin 
(GE Healthcare) according to manufacturer protocols, eluted with 10 mM 
glutathione at pH 7.4, and dialyzed to remove glutathione. 6x-histidine tagged 
lin28a and truncations were likewise harvested and purified using cOmplete His-
Tag purification resin (Roche) according to manufacturer protocols and eluted 
with 100 mM imidazole, again followed by dialysis. 
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For in vitro immunoprecipitation, equimolar 6xHis-tagged lin28a 
truncations (equimolar to a 50 ug mass of lin28a-3) were bound overnight to Ni-
NTA bead slurry, then mixed with 100 ug GST TRBP dD or equimolar GST 
peptide and rotated for 3 hours at 4C in PBS. Mixture was washed with 20x bead 
volume and then eluted with high concentration imidazole or by boiling in SDS 
gel loading buffer. Protocol for protein purification and binding assay are 
reproduced below: 
 
Protocol for protein purification: 
Day 1: 
1) Inoculate 10ml TB plus antibiotic with 1 colony from BL21 bacteria 
transformed with plasmid of interest 
Note: Touch pipette tip to colony, then touch tip to 5ml LB/antibiotic 
liquid culture and eject tip in a second 5ml LB/antiobotic liquid 
culture 
Day 2: 
1) Inoculate 250ml TB/antibiotic with 10ml starter culture from Day 1. Grow at 
37C 
2) Monitor bacterial growth until OD 600 = 0.75 (logarithmic phase, usually 
about 2 hrs of growth) 
3) Once OD 600=0.75, add IPTG to final concentration of 1mM to induce 
plasmid expression, and grow for 2 - 4 hrs 
4) Cool bacteria quick on ice water bath for 15-25 min 
113 
 
5) Spin down bacteria at 7700 x g for 10 min at 4C 
6) Resuspend bacterial pellet in 12.5ml cold PBS, pH=7.4 
Note: At this step, bacterial resuspension can be stored overnight 
at  -20C to aid lysis. Alternatively, experimenter can proceed 
immediately to the subsequent steps 
Day 3: 
Lysis 
1) Quick thaw bacteria at 37C  
2) Add bacterial protease inhibitors to recommended concentration, and 
lysozyme to 0.5mg/ml 
3) Incubate 30 min room temp 
4) OPTIONAL: freeze bacteria and thaw at 37C 2-3X to aid lysis 
5) Sonicate: 20 sec pulses X 5, at 20% amplitude 
6) Add Triton-X to 1% and incubate on ice 0-10 min 
7) Spin 10,000 x g for 10 min at 4C. Take supernatant for analysis. 
Note: If desired, save supernatant sample for analysis of protein 
expression 
Pull-down 
1) Wash 1200 uL 30% bead slurry with PBS, pH=7.4 (about 400uL bed 
volume of beads; glutathione sepharose beads for GST binding, or Ni-
NTA beads for 6x His binding). 
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2) Allow beads to settle into a pellet on ice (approx. 15 minutes); resuspend 
beads as 25% slury in PBS, pH = 7.4 (i.e., 1200uL PBS to 400 uL bed 
volume of beads) 
 To expedite, beads may be pelleted with a 30 second spin at 2500 
rpm at 4 C. 
3) Add 12.5ml lysed bacterial supernatant to 1600l 25% slurry of 
appropriate beads  
4) Rotate beads and supernatant at 4C for 2hr-overnight 
 
Ni-NTA column elution: 
1) Spin down Ni-NTA beads at 500 x g for 5 min at 4C and decant 
supernatant 
Note: Save supernatant sample for analysis of % protein pull-down 
2) Re-suspend beads in small volume PBS, pH=7.4 (around 500l) and 
apply to Biorad Poly-prep chromatography column 
3) Wash with 8ml PBS + 25 mM imidazole, pH=7.4 (20X bead volume) and 
collect drainage 
Note: Save wash drainage sample to confirm protein is not lost 
4) Elute using one bed-volume into 200l fractions with freshly made 250 
mM imidazole in 1x PBS, pH 7.4 
a. Plug column before addition of each elution fraction, and 
incubate 50-10 min before collecting elution 
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b. Add 1l eluted fraction to 100l Bradford reagent to preliminarily 
select for concentrated fractions.  
NB: BCA reagent cross-reacts with both glutathione and 
imidazole.  
5) Pool most concentrated fractions and subject to dialysis at 4C to remove 
imidazole 
a. Dialysis buffer: 20mM HEPES pH=8.0, 20% glycerol, 0.2 mM 
EDTA, 1mM DTT 
b. Use slide-a-lyze tubes with 20K pore size 
c. Dialyze for 2 hours, change dialysis buffer, then let go overnight. 
6) Quantitate protein concentration by BCA protein assay and snap freeze 
using ethanol and dry ice; store at -80C 
 
Binding assay 
1) Wash 60l 30% Ni-NTA bead slurry with cold PBS, pH=7.4 and resuspend 
in 20l to make 50% slurry 
2) Rotate about 50g of either GST-TRBPWT, GST-TRBPSD, or GST 
alone with 40l 50% glutathione sepharose bead slurry, 2hrs-overnight at 
4C 
3) Add about 25g pure Lin28a protein to bead-bound GST-TRBPWT, GST-
TRBPSD, or GST alone (approximately 2X TRBP per 1X Lin28a) 
4) Rotate 2-4hrs, 4C 
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5) Wash 3X with cold PBS, pH=7.4, by adding 1.5ml to each tube, inverting, 
centrifuging at 2000 x g for 30 sec, and suctioning off buffer 
6) Add 60l PBS with SDS loading buffer to each sample and boil for 8-10 
min to elute. Analyze samples by immunoblot. 
Note: use tube cap to prevent loss of volume while boiling 
 
 
Epifluorescence Imaging:  
 Live cell fluorescence and FRET imaging were conducted on a Zeiss 
Axiovert 200M microscope controlled by Metafluor 6.2 software. Cells seeded on 
poly(L)lysine coated glass-bottom imaging dishes (MatTek Corporation) were 
incubated at 37 C in Hank’s Balanced Salt Solution (HBSS), and imaged at 40x 
magnification with 50% neutral density filters, illuminated by an arc lamp and 
captured on a cooled charge coupled device (Photometrics). Fluorescence 
emission was collected from cyan fluorescent protein (420DF20 excitation filter, 
500 ms excitation, 475DF40 emission filter); yellow fluorescent protein (420DF20 
excitation for 50 ms, 535df25 emission filter); sensitized YFP emission (CFP 
excitation and YFP emission); and red fluorescent protein (568DF55 excitation 
filter, 50ms, 600DRLP dichroic mirror, 653DF95 emission filter). 
 For endpoint FRET imaging, cells expressing CFP-tagged TRBP or a 
truncation and YFP-tagged lin28a or a truncation were serum starved for 
approximately fifteen minutes in imaging media. Several images were taken to 
establish a baseline, followed by 90 second, 3 minute and 5 minute illumination 
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at 504 nm to bleach YFP. Images were quantified using MetaFluor 6.2 software 
(Universal Imaging). FRET efficiency was calculated based on the recovery in 
background-corrected CFP brightness after YFP bleaching, using the following 
formula:  
FRET efficiency = 1-Fda/Fd 
 where Fda is the CFP fluorescence observed when both donor and acceptor are 
active, and Fd,is the fluorescence observed after YFP photobleaching. To confirm 
complete photobleaching, percent change in YFP intensity was calculated, using 
the formula: 
% photobleaching = [(intensity final-intensity initial)/intensity initial] * 100% 
Only dishes with an average reduction of 80% or more in YFP signal were used 
for FRET efficiency calculation in epifluorescence experiments. 
For time-course FRET imaging, cells expressing CFP-tagged TRBP-B 
with YFP-tagged Lin28a-3 were serum starved (0.5-2 hrs) in imaging media, then 
imaged every 30 s. CYFRET, CFP, YFP and RFP intensity in each ROI were 
measured over time using MetaFluor software and, after background subtraction, 
used to calculate the normalized FRET emission ratio, a measure that adjusts for 
expression level and spectral bleedthrough of donor and acceptor fluorophores 
(Xia & Liu, 2001).  
NFRET = FRET intensity – [YFP intensity x a] – [CFP intensity x b] 
NFRET ratio = NFRET/CFP 
Bleedthrough value “a” was determined using cells expressing only YFP, 
then imaged in both the CYFRET and YFP channels. “A” was defined as the 
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signal in the YFRET channel as a percent of YFP signal; on this system, the 
value used was 0.14. Bleedthrough value “b” was calculated using the same 
approach with CFP alone, and came to 0.32. Representative images shown in 
figure 5E have had NFRET value calculated using the Image Calculator function 
in ImageJ to perform the same series of calculations  (i.e., mean background 
subtraction in each channel, followed by subtraction of estimated bleedthrough 
from CFP and YFP direct channels, applied to CYFRET channel).  
 
Confocal imaging 
 Live neuron FRET imaging was conducted on a Zeiss LSM 780 
microscope at 63x magnification using an oil immersion objective, with NA of 1.4. 
Hippocampal neuronal cultures expressing the indicated fluorescent construct 
were allowed to equilibrate in Tyrode’s buffer and then imaged at 37 C after 24 to 
30 hours of transfection (14 days in vitro). Where indicated, BDNF was added to 
100 ng/mL in imaging media, either for thirty minutes prior to imaging (figure 
2.6B) or after baseline imaging (figure 2.6C). 
 DsRed channel was excited with 2.0% laser intensity (DPSS 561), with 
wavelengths from 570-668 nm collected through a 58 nm pinhole to a gallium 
arsenide phosphide (GaAsP) detector. Gain settings were optimized for contrast 
of transfected cells against background. CFP/CYFRET channel was excited with 
1.2% argon laser intensity at 458 nm, and collected through a 40.4 um pinhole 
with wavelengths 463-508 nm (CFP emission) sent to the GaAsP detector, and 
wavelengths 520-605 nm (sensitized YFP emission) collected in a photomultiplier 
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tube. YFP direct emission channel was excited using 0.6% argon laser intensity 
at 514 nm, collected once again through a 40.4 nm pinhole to the GaAsP 
detector, with wavelengths 520 to 615 nm. 109.4x109.4 um images (pixel size = 
0.11 um square) were collected at scan speed 5, a dwell time of 6.3 usec per 
pixel.  
 Photobleaching was carried out on the confocal microscope using the 514 
nm laser at 50% intensity at scan speed 4, a dwell time of 12.6 usec per pixel. 
Full Z-stacks were scanned three times with this paradigm, after which a 
bleached image was collected using the settings described above. 
 
Epifluorescence Image analysis 
 When possible, image analysis was carried out using Metafluor imaging 
software. Regions of interest were selected by hand, and a screenshot was 
saved for future reference. When imaging region shifted in the XY plane, all 
regions of interest were shifted accordingly. 
 When Metafluor was unavailable, Metafluor output images were opened in 
Fiji (ImageJ) using the Bioformats Importer plugin. One stack was generated 
from each channel. To control for minor XY shifts, all stacks were registered with 
the StackReg plugin (using the ImageJ “StackReg” plugin, July 2011 distribution 
(Thevenez et al., 1998)) using the “rigid body transformation” setting. Regions of 
interest were selected in one channel and reproduced in other channels using 
the ROI Manager tool. Within each image, a background region of interest was 





 When reanalyzing Metafluor .log files to generate NFRET data shown in 
figure 2.5, a macro was written in Excel Visual Basic (VBA) to extract logged 
data. Code is reproduced in the Code Appendix, Macro 2.   
 
 
Confocal image analysis 
 Neuron imaging datasets, saved as .czi files at “baseline” and “bleached” 
timepoints using Zen software (Zeiss, Oberkochen, Germany) were initially 
analyzed in three dimensions. Using Imaris image analysis software 
(Bitplane/Oxford Instruments, version 7.7.2), neuron images were masked with 
mCherry for processing. Threshold varied according to transfection efficiency. 
Regions of interest were selected in 3 dimensions to delineate dendritic shaft and 
spine; mean pre- and post-bleaching values per um3 in YFP and CFP intensity 
within each region were used to calculate % YFP bleaching and FRET efficiency 
using the formulas described above. However, negative control cells expressing 
only CFP, which should show no FRET, tended to yield artificially high and 
extremely noisy apparent FRET efficiency values using this analysis strategy. 
The noise observed in apparent FRET efficiency in Imaris may have stemmed 
from a high degree of noise in CFP collection and a failure to replicate three-
dimensional regions of interest accurately across timepoints. The reason for the 
positive average was not determined. However, analyzing a maximum intensity 
projection (MIP) of cells expressing CFP alone showed an appropriate average 
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FRET efficiency about zero. Therefore, images were condensed in ImageJ, using 
a custom ImageJ macro, which extracts pre- and post-bleach maximum intensity 
projections in each channel from .czi files composed of four channels (CFP, 
CYFRET, YFP, RFP). Code is reproduced (with comments) in the Coding 
appendix. 
 After construction and registration (using the ImageJ “StackReg” plugin) of 
maximum intensity projection images, an average of five dendritic regions of 
interest per neuron were generated and average intensity was measured at pre- 
and post-bleach timepoints in all channels. These values were used to calculate 
% YFP bleach and FRET efficiency as decribed above. 
 
Statistical analyses 
 All quantified data represent mean +/- SEM. Statistical analysis included 
one-way ANOVA for independent samples with a Bonferroni post hoc test, α = 
0.05, comparing to Lin28a alone or comparable condition. Where noted, two-
tailed student’s t tests were used for pairwise comparison of untreated and 
treated conditions. Linear regression analysis and slope significance testing were 
carried out using a Graphpad Prism protocol equivalent to ANCOVA.  Before 
linear regression was performed, independent variables were subjected to a 
Grubb’s test with α = 0.05. The result was used to justify removing one 




Appendix 2: Image analysis macros 
 
Macro 1: Generate multi-channel, multi-timepoint maximum intensity 
projections from XYZC .czi images (ImageJ) 
 
When run using Fiji/ImageJ (Schindelin et al., Nature Methods 2012) this macro 
will open a pair of XYZC image stacks with the file names “baseline.czi” and 
“bleached.czi” saved in a user-defined directory (i.e., a folder) according to date 
and dish number. The macro will make a maximum intensity projection of each 
channel (up to 4 channels) from each image; concatenate the resulting single-
frame MIPs, ordered as “channel1-baseline”, “channel1-bleached”,  “channel2-
baseline,” etc. The user is then presented with an opportunity to select regions of 
interest, which are measured in all channels; measurement outputs and ROI 




macro "define baseline & bleached" {   
 
var path = getDirectory("Choose a directory") // user chooses a 
directory for imaging date/dish/etc. from file storage location 
 
var baseline = "baseline.czi" ; 
var bleached = "bleached.czi" ; 
print(path+baseline); //confirms location and name of files to be 
condensed 
 
// var datedish = file.directory.substring(path.lastIndexOf('/') + 1); 
//non-operational code, tries to extract part of the file path that 
gives date & dish information. 
 
run("Bio-Formats Importer", "open=["+path+baseline+"] autoscale 
color_mode=Composite concatenate_series display_metadata display_ome-
xml rois_import=[ROI manager] split_channels view=Hyperstack 
stack_order=XYCZT"); //opens baseline.czi, as stacks separated by 




run("Bio-Formats Importer", "open=["+path+bleached+"] autoscale 
color_mode=Composite concatenate_series display_metadata display_ome-
xml rois_import=[ROI manager] split_channels view=Hyperstack 
stack_order=XYCZT"); // opens bleached.czi, as stacks separated by 
fluorescence channel 
 
// make MIPs of baseline images 
for( i=0; i<4; i++ ) { // sets up a loop for 4-channel images   
 selectWindow("baseline.czi - C=" + i); //chooses baseline stack 
in channel (1:4) 
 run("Z Project...", "projection=[Max Intensity]"); //makes MIP of 
channel 
 selectWindow("baseline.czi - C=" + i);  




// now do (bleached)  
 
for( i=0; i<4; i++ ) {  
 selectWindow("bleached.czi - C=" + i);  
 run("Z Project...", "projection=[Max Intensity]");  




// concatenate a series of maximum intensity projections 
var MIP = "MIP" 
var array = split(path, "/") //splits file path by folder (e.g., 
“~/Documents/Imaging/Date/Dish“ becomes a vector including “Documents”, 
“Imaging”, “Date”, “Dish” 
 
var datedish = array[array.length-2]+"-"+array[array.length-1] 
//expresses a unique file path for new MIP image 
 
run("Concatenate...", "title=["+datedish+MIP+"] 
image1=[MAX_baseline.czi - C=0] image2=[MAX_bleached.czi - C=0] 
image3=[MAX_baseline.czi - C=2] image4=[MAX_bleached.czi - C=2] 
image5=[MAX_baseline.czi - C=3] image6=[MAX_bleached.czi - C=3] 
image7=[-- None --]");  // concatenates together MIPs pre and post 








macro "measure all three with the same ROIs" 
// open file : .tif of stack 
//open ROI manager tool 
roiManager("reset") //deletes ROIs from previous setup 
//PAUSE FOR USER INPUT: ROIs of interest 
roiManager("multi measure") //multi-measure ROIs in each, save output 
roiManager("save,) //save ROIs- **user must input a file-path here! ** 







   
Macro 2: Calculate NFRET from CYFRET/CFP/YFP/RFP measurements 
saved in Metafluor output .LOG files (Excel) 
 
This macro was developed using the Excel visual basic editor to calculate 
NFRET (bleedthrough-corrected FRET value) from comma-separated .LOG 
datasets exported from Metafluor, with the following layout, which varied 
according to number of ROIs, with “R” indicating region number and “W” 




        
Date         
Region 1: 
(coordinates) 
        
Region 2: 
(coordinates) 
        
…         
Region n: 
(coordinates) 
        
















001 ## ## ## ## ## ## ##  
002 ## ## ## ## ## ## ##  
 
The data layout varied according to number of regions specified in Metafluor 
(with the last defined ROI always chosen to cover a background region) and the 
number of timepoints collected. Therefore, the macro includes commands to 
count both regions of interest and timepoints, and subtract the background 
intensity in each channel from each region of interest for all timepoints. For 
NFRET calculation, the CFP bleedthrough correction varied according to the 
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CFP variant expressed (ECFP, Cerulean, or Cerulean3). Therefore, the macro 
assumes user input of an experimentally measured CFP bleedthrough correction 
value (that is, the CYFRET/CFP intensity ratio in an image of cells expressing 




    'define variables 
    regions = Sheet1.Range("A:A").Find("Time (sec)").Row - 3 
    timepoints = Sheet1.Range("A:A").Find(blankcell).Row - regions - 3 
    cfpcorr = Cells(1, 3) 
    substart = timepoints + regions * 2 
     
    'calculate NFRET 
    For j = 1 To timepoints 
    For i = 1 To ((regions - 1) * 5) Step 5 
        If (IsNumeric(Cells(substart + j, i + 1))) Then 
        Cells(substart + regions + timepoints + j, i + 1) = 
Round((Cells(substart + j, i + 1) - (cfpcorr * Cells(substart + j, i + 
2)) - (0.1 * Cells(substart + j, i + 3))), 3) 
         
        End If 
    Next i 
    Next j 
     
     'calculate NFRET/CFP 
    For j = 1 To timepoints 
    For i = 1 To ((regions - 1) * 5) Step 5 
        If (IsNumeric(Cells(substart + regions + timepoints + j, i + 
1)) And (Cells(substart + regions + timepoints + j, i + 1)) <> 0) Then 
        Cells(substart + regions + timepoints + j, i + 2) = 
Round((Cells(substart + regions + timepoints + j, i + 1) / 
Cells(substart + j, i + 2)), 6) 
        End If 
   Next i 
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